3-acyl-benzamides and use thereof as herbicides

Abstract

The invention relates to 3-acyl-benzamides of formula (I) as herbicides. In formula (I), X, Y, Z and Rx are groups such as alkyl, cycloalkyl, haloalkyl and halogen.

Description

[0001]BCS231018 Ausland Mak / lep 2024-08-06 - 1 - 3-Acyl-benzamides and their use as herbicides. The invention relates to the technical field of herbicides, in particular to that of herbicides for the selective control of weeds and grass weeds in crops. WO 2012 / 028579 A1 discloses herbicidally active benzamides which can carry a multiplicity of substituents in the 3-position of the phenyl ring. WO 2001575 / 067 A1, EP 3118199 A1 and WO 2017 / 055146 A1 likewise describe herbicidally active phenylamides which can carry a multiplicity of substituents in the 3-position of the phenyl ring. Furthermore, these documents, under example numbers 1-364 to 1-367 and 1-426 to 1-429, each contain individual phenylamides that carry an acetyl or cyclopropylcarbonyl residue in the 3-position of the phenyl ring. Finally, specific 3-acylbenzamides are described in WO2019 / 25540.However, the benzoylamides known from the above-mentioned documents do not always exhibit sufficient herbicidal resistance and / or compatibility with crop plants. The object of the present invention is to provide alternative herbicidally active ingredients. This object is achieved by the benzamides according to the invention described below, which carry an acyl radical in the 3-position of the phenyl ring and a halogenoalkoxy radical in the 4-position. The present invention relates to 3o-methoxybenzamides of the formula (I) or salts thereof. where the symbols and indices have the following meaning: R x means (C1-C6)-alkyl, Halogen-(C1-C6)-alkyl, (C1-C6)-alkyl-O-(C1-C6)-alkyl or (C3-C6)-cycloalkyl-(C1-C6)-alkyl, where (C3-C6)-cycloalkyl is replaced by m radicals1 R is substituted, R 1 means halogen, (1C-C6)-alkyl, halogen-(C1-C6)-alkyl or (C1-C6)-alkyl-O, and m means 0, 1, 2 or 3. BCS231018 Foreign countries - 2- In formula (I) and all subsequent formulae, alkyl radicals having more than two carbon atoms can be straight-chain or branched. Alkenyl radicals denote, for example, methyl, ethyl, n- or i-propyl, n-, i-, t- or 2-butyl, pentyl, hexyl, n-hexyl, i-hexyl and 1,3-dimethylbutyl. Analogously, alkenyl denotes, for example, allyl, 1-methylprop-2-en-1-yl, 2-methyl-prop-2-en-1-yl, but-2-en-1-yl, but-3-en-1-yl, 1-methyl-but-3-en-1-yl and 1-methyl-t-2-en-1-yl. Alkynyl means, for example, propargyl, but-2-yn-1-yl, but-3-yn-1-yl, 1-methyl-but-3-yn-1-yl. The multiple bond can be in any position of the unsaturated radical. Cycloalkyl means a carbocyclic, supported ring system with three to six carbon atoms, such as cyclopyrrole, cyclobutyl, cyclopentyl, or cyclohexyl. Halogen represents fluorine, chlorine, bromine, or iodine. The compounds of formula (I) or (II) can exist as stereoisomers, depending on the nature and linkage of the substituents.If, for example, one or more asymmetrically substituted carbon atoms are present, enantiomeric diastereomers can occur. Stereoisomers can be obtained from the mixtures obtained during production by conventional separation methods, for example by chromatographic separation processes. Stereoisomers can also be selectively prepared by using stereoselective reactions using selective starting materials and / or auxiliaries. The invention also relates to stereoisomers and mixtures thereof which are encompassed by formula (I) or (II) but are not specifically defined. Preference is given to compounds of formula (I) in which the symbols and indices have the following meanings: R. xmeans (C1-C6)-alkyl, (C2-C6)-alkynyl, halogen-(C1-C6)-alkyl, (C1-C6)-alkyl-O-(C1-C6)-alkyl or (C3-C6)-cycloalkyl-(C1-C6)-alkyl, where (C3-C6)-cycloalkyl is replaced by m radicals 1 R is substituted, R 1 means halogen, (1C-C6)-alkyl or halogen-(C1-C6)-alkyl, and m means 0, 1 or 2. Particularly preferred compounds are of the formula)e,lw (oIrin the symbols and indices have the following meanings: R x means Me, Et X means chlorine, bromine, methyl, ethyl or cyclopyrrole, BCS231018 Foreign countries - 3- Y is OC3F, OCHF2 or OCH2CHF2 and Z is methyl, ethyl, n-propyl, isopropyl, cyclopropyl, butyl, isobutyl, sec-butyl, vinyl, allyl, ethynyl, prop-1-yn-1-yl, methoxymethyl, chloromethyl, cyclopropylmethyl, 1-methylcyclopropyl or difluoromethyl. In all formulas mentioned below, the best situations and symbols, unless otherwise defined, have the same meaning as described under formula (I). Compounds of formula (II) are novel and very suitable as intermediates for the preparation of the compounds of formula (I) according to the invention. The present invention thus also relates to compounds of formula (II), where the symbols and indices have the following meaning: L means halogen or 2OR, (C1-C6)-alkyl-O-(C1-C6)-alkyl or (C3-C6)-cycloalkyl-(C1-C6)-alkyl, where (C3-C6)-cycloalkyl is replaced by m radicals 1 R is substituted, R 1 means halogen, (1C-C6)-alkyl, halo-(C1-C6)-alkyl or (C1-C6)-alkyl-O, and R2 means hydrogen or 1-(C6)-alkyl. Preferred compounds (II) are those in which L means chlorine, methoxy or hydroxy, X means chlorine, bromine, methyl or ethyl or cyclopropyl, Y means OC3F, OCHF2 or OCH2CHF2 and Z means methyl, ethyl, n-propyl, isopropyl, cyclopropyl, butyl, isobutyl, sec-butyl, vinyl, allyl, ethynyl, prop-1-yn-1-yl, methoxymethyl, chloromethyl, cyclopropylmethyl, 1-methylcyclopropyl or difluoromethyl. BCS231018 Foreign Countries - 4In all formulas mentioned below, the best situations and symbols, unless otherwise defined, have the same meaning as described under formula (Is). Compounds according to the invention of the general formula (mI) can be prepared, for example, as also described in WO2012 / 028579, by reacting the compounds according to the invention of the general formula (IIb: compounds II, where: g LiI = hydroxy) with substituted aminotetrazoles: The synthesis of the compounds of the general Flo (rImIbe) can be carried out, for example, according to the following scheme and methods known to the person skilled in the art: Collections of compounds of formula (I) and / or their salts, which can be synthesized by the above-mentioned reactions, can be prepared in a characterized manner, which can be done manually, partially automated or completely automated. For example, it is possible to automate the reaction procedure, the work-up or the purification of the products or intermediates. In essence, this is understood to mean a procedure such as that described, for example, by D. Tie in Combinatorial Chemistry - Synthesis, Analysis, Screening (editor Günther Jung), Verlag W 119le9y9, on pages 1 to 34.For parallelized reaction execution and processing, a number of commercially available devices can be used, for example Cialpyso reaction blocks from Barnstead International, Dubuq Iouwe, a 52004-0797, USA or reaction stations from Radleys, Shirehill, of Son Walden, Essex, CB 11 3AZ, England or MultiPROBE Automated Workstations from Per Ekilnmar, Waltham, Massachusetts 02451, USA. For the parallelized purification of compounds of the formula (I) and their salts or of intermediates obtained during their preparation, BCS231018 Ausland - are available, among others. 5Chromatography equipment is available, for example from ISCO, Inc., 4700 Superior Street, Lincoln, NE 68504, USA. The equipment listed leads to a complex procedure in which the individual work steps are automated, but manual operations must be carried out between the steps. This can be avoided by the use of partially or fully integrated automation systems in which the respective automation modules are operated, for example, by robots. Such automation systems can be obtained, for example, from Caliper, Hopkinton, MA 01748, USA. The implementation of individual or multiple synthesis techniques can be supported by the use of polymer-supported reagents / scavenger resins. A number of experimental protocols are described in the specialist literature, for example, ChemFiles, Vol. 4, No.1, Polymer-Supported Scavengers and Reagents for Solution-Phase Systems (hSeigsmi a-Aldrich). In addition to the methods described here, the isolation of compounds of formula (I) and their salts can be carried out completely or partially by solid-phase-supported methods. For this purpose, individual intermediates or all intermediates of the synthesis, or of a synthesis adapted for the corresponding procedure, are linked to a syntheses reaction. Solid-phase-supported synthesis methods are described in the specialist literature below, e.g., Barry A. Bunin in "The Combinatorial Index", Academic Press, 1998, and Combinatorial Chemistry - Synthesis, Analysis, Screening (editor Günther Jung), Wil 1996, 1999. The use of solid-phase-supported synthesis methods allows consistency with known-temperature protocols, which can be carried out manually or automatically.These reactions can be carried out, for example, using IRORI technology in microreactors from Nexus Biosystems, 12140 Community Road, Poway, CA 92064, USA. Both in the solid and liquid phase, the implementation of individual or multiple synthesis steps can be supported by the use of microwave technology. A number of experimental protocols are described in the specialist literature, for example in Microwaves in Organic and Medicinal Chemistry (editors: C.O. Kappe and S.D. a.d.ler), Wiley Publishers, 2005. Preparation according to the procedure described here yields compounds of formula (I) and their salts in the form of substance collections called libraries. The present invention also relates to libraries containing at least two compounds of formula (I) and their salts.The compounds according to the invention exhibit a marked herbicidal activity against a broad spectrum of economically important mono- and dinidotylous annual weeds. Even difficult-to-control perennial weeds that sprout from stems, rootstocks, or other permanent organs are effectively controlled by the active ingredient. BCS231018 Abroad -. 6The present invention therefore also relates to a method for controlling undesirable plants or for regulating the growth of plants, preferably in plant crops, in which one or more compounds according to the invention are applied to plants (e.g. harmful plants such as mono- or dicotyledonous weeds or undesirable crop plants), to seeds (e.g. grains, seeds or vegetative propagation organs such as tubers or shoot parts) or to the area on which the plants grow (e.g. the cultivation area). The compounds according to the invention can also be applied, for example, by pre-sowing (optionally also by incorporation into the soil), pre-emergence or post-emergence methods. Some representatives of the mono- and dicotyledonous weed flora which can be controlled by the compounds according to the invention are mentioned individually as examples, without this being intended to result in a restriction to specific species.Monocot harmful plants of the genera: Aegilopgsr,o Apyron, Agrostis, Alopecurus, Apera, Avena, Brachiaria, Bromus, Cenchrus, Commelina, Cynodoynp,e Crus, Dactyloctenium, Digitaria, Echinochloa, Eleocharis, Eleusine, Eragrostis, Eriochloa, Feas,tu Fcimbristylis, Heteranthera, Imperata, Ischaemum, Leptochloa, Lolium, Monochoria, Panicum, Paspalu Pmh,alaris, Phleum, Poa, Rottboellia, Sagittaria, Scirpus, Setaria and Sorghum.Dicotyledonous weeds of the genera: Abutilon, Amarhaunst, Ambrosia, Anoda, Anthemis, Aphanes, Artemisia, Atriplex, Bellis, Bidens, Capsella, Cuaurds, Cassia, Centaurea, Chenopodium, Cirsium, Convolvulus, Datura, Desmodium, Emex, Erysimum, h Eourpbia, Galeopsis, Galinsoga, Galium, Hibiscus, Ipomoea, Kochia, Lamium, Lepidium, Linndiear, Matricaria, Mentha, Mercurialis, Mullugo, Myosotis, Papaver, Pharbitis, Plantago, Polygon Puomrt,ulaca, Ranunculus, Raphanus, Rorippa, Rotala, Rumex, Salsola, Senecio, Sesbania, Sida, Sinaoplaisn,u Sm, Sonchus, Sphenoclea, Stellaria, Taraxacum, Thlaspi, Trifolium, Urtica, Veronica, Viola and Xtahnium. If the compounds according to the invention are applied to the soil surface before the rain, either the emergence of weed seedlings is prevented from occurring or the weeds grow to the cotyledon stage, but then cease growth and finally die completely after three to four weeks.When the active ingredients are applied post-emergence to the green parts of the plant, growth stops after treatment and the weeds remain in the growth stage present at the time of application or die completely within a certain time, so that weed competition harmful to the crop plants is eliminated very early and sustainably. Although the compounds according to the invention have considerable herbicidal activity against mono- and dicotyledonous weeds, cultivated plants of economically important crops, e.g. dicotyledonous crops of the genera Arachis, Beta, s Bsriaca, Cucumis, Cucurbita, Helianthus, Daucus, Glycine, Gossypium, Ipomoea, Lactuca, Linum, Lycrospiceon, Miscanthus, Nicotiana, Phaseolus, Pisum, BCS231018 abroad -. 7- Solanum, Vicia, or monocotyledonous crops of the genus Allium, Ananas, Asparagus, Avena, Hordeum, Oryza, Panicum, Saccharum, Secale, Sorghum, Tlericicum, Tarticum, Zea, especially Zea and Triticum, are only slightly damaged or not damaged at all, depending on the structure of the respective compound according to the invention and the application rate. For these reasons, the above-mentioned compounds are very suitable for the selective control of undesirable plant growth in plant crops such as agricultural crops or ornamental plants. Furthermore, the compounds according to the invention, depending on their respective chemical structure and the application rate, exhibit significant growth-regulatory properties in crop plants. They regulate the plant's own metabolism and can therefore be used to specifically influence plant content and facilitate harvesting, for exampleby inducing desiccation and stunting. Furthermore, they are also suitable for the general control and inhibition of uncontrolled vegetative growth without killing the plants. Inhibition of vegetative growth plays a major role in many monocotyledonous and dicotyledonous crops, as it can reduce or completely prevent, for example, vegetable growth. Due to their herbicidal and plant growth-regulating properties, the active ingredients can also be used to control weeds in crops modified by genetic engineering or conventional mutagenesis.Transgenic plants are generally characterized by particularly advantageous properties, for example, resistance to certain pesticides, especially certain herbicides, resistance to plant diseases or pathogens of plant diseases such as certain insects or microorganisms such as fungi, bacteria or viruses. Other special properties relate to the harvested product in terms of quantity, quality, storability, composition and special properties. For example, transgenic plants with increased starch content or altered quality of the starch, as well as those with a different fatty acid composition of the harvested product, are known. With regard to transgenic crops, the use of the compounds according to the invention is preferred in economically important transgenic crops, such as ornamental plants, e.g.of cereals such as wheat, barley, rye, oats, millet, rice, and yam, as well as crops of sugar beet, cotton, soybeans, rapeseed, potatoes, cassava, tomatoes, peas, and other vegetables. The compounds according to the invention can preferably be used as herbicides in crops that are resistant to the phytotoxic effects of the herbicides or have been made resistant by genetic engineering. Conventional methods for producing new plants that have modified properties compared to previously occurring plants usually consist of classical breeding methods and the creation of mutants. Alternatively, new plants with modified properties can be produced using BCS231018. 8- produced by genetic engineering techniques (see e.g. EP BA-0221044, EP-A-0131624). For example, several cases have been described: - genetic modifications of crop plants by modifying the starch synthesized in the plants (e.g. WO 92 / 11376, WO 49822 / 17, WO 91 / 19806), - transgenic crop plants which are resistant to certain chemobicides of the glufosinate type (cf. e.g. EP-A-0242236, EP-A-242246) or glyphosate (WO009327 / 7) or sulfonylureas (EP-A-0257993, US-A-5013659), - transgenic crop plants, for example Baumlew,o ml, with the ability to produce Bacillus thuringiensis toxins (Bt toxins), which make the plants resistant to certain pests (EP-A-0142924, EP-A-0193259). - transgenic crop plants with modified fatty acid composition (WO 91 / 13972). - genetically modified crop plants with new amino acids or secondary substances, e.g.new phytoalexins that cause increased disease resistance (EPA 309862, EPA0464461) - genetically modified plants with reduced orthoprespiration that exhibit higher yields and greater stress tolerance (EPA 0305398). - transgenic crops that produce pharmaceutically important proteins ("molecular pharming") - transgenic crops that are characterized by higher responsiveness or better quality - transgenic crops that are characterized by a combination of the new properties mentioned above ("gene stacking"). Numerous molecular biological techniques with which new transgenic plants with modified properties can be produced are known at present, see e.g. BI Potrykus and G. Spangenberg (eds.) Gene Transfer to Plants, Springer Lnagbe Manual (1995), Springer Verlag Berlin, Heidelberg. or Christou, "Trends in Plant Science" 1c (e1996) 423-431).For such genetic manipulations, nucleotide molecules can be introduced into plasmids, allowing mutagenesis or sequence alteration through recombination of DNA sequences. Using standard procedures, nucleotide exchanges can be performed, partial sequences removed, or natural or synthetic sequences added. To connect the DNA fragments to one another, ligands or linkers can be attached to the fragments, see, for example, Sambrook et al., 1989, Molecular Cloning, A Laboratory Manual, 2nd ed., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, or Winnacker "Given the Cloning," VCH Weinheim, 2nd ed., 1996, BCS231018. 9- The production of plant cells with increased activity of a gene product can be achieved, for example, by expressing at least one corresponding antisense RNA, a sense RNA to achieve a cosuppression effect, or the expression of at least one appropriately constructed ribozyme that cleaves specific transcripts of the above-mentioned gene product. For this purpose, DNA molecules can be used that comprise the entire coding sequence of a gene product, including any potentially present cross-linking sequences, as well as DNA molecules that contain only parts of the coding sequence. These parts must be long enough to produce an antisense effect in the cells. It is also possible to use DNA sequences that exhibit a high degree of homology to other sequences of a gene product, but are not completely identical.When nucleic acid molecules are expressed in plants, the synthesized protein can be expressed in any compartment of the plant cell. However, to achieve localization in a specific compartment, the coding region can be linked to DNA sequences that ensure localization in a specific compartment. Such sequences are known to the person skilled in the art (see, for example, Berta et al., EMBO J. 11 (1992), 3219-3227, Wolter et al., Proc. Natl. Acad. Sci. USA 85 (1988), 84560-8561, Sonnewald et al., Plant J. 1 (1991), 95-1068). Expression of the nucleic acid molecules can also take place in the cellular compartments of plant cells. The transgenic plant cells can be regenerated into whole plants using known techniques. The transgenic plants can, in principle, be any plant species, i.e., both monocotyledonous and dicotyledonous plants.Thus, transgenic plants are obtainable which exhibit damaging properties through overexpression, suppression, or inhibition of homologous (= natural) gene sequences or expression of heterologous (= foreign) genes or gene sequences. The compounds according to the invention can preferably be used in transgenic crops which are resistant to growth promoters, such as dicamba, diglyceride-resistant herbicides which inhibit essential plant enzymes, e.g., acetolactate synthases (ALS), EPSP synthases, glycine synthases (GS), or hydroxyphenylpyruvate dioxygenases (HPPD), or to herbicides from the group of sulfonylureas, glyphosate, glufosinate, or benzoyl isoxazole, and are resistant to non-invasive active ingredients.When the active ingredient according to the invention is used in transgenic crops, in addition to the effects observed in other crops against herbaceous plants, effects often occur that are superior to application in the respective transgenic crop, for example a modified or specifically expanded weed spectrum that can be controlled, modified application rates that can be used, preferably good combinability with the herbicides to which the transgenic crop is resistant, and the influence on growth and yield of the transgenic crops. BCS231018 Abroad -. 10The invention therefore also relates to the use of the compounds according to the invention as herbicides for controlling harmful plants in grassy crops. The compounds according to the invention can be applied in the form of spray powders, emulsifiable concentrates, sprayable solutions, dusts, or granules, in addition to the customary preparations. The invention therefore relates to herbicides and plant growth-regulating agents containing the compounds according to the invention. The compounds according to the invention can be formulated in various ways, depending on the biological and / or chemical-physical parameters required.Examples of possible formulations include: wettable powders (WP), water-soluble powders (SP), water-soluble concentrates, emulsifiable concentrates (EC), emulsions (EW), such as oil-in-water and water-in-oil emulsions, sprayable solutions, suspension concentrates (SC), oil- or water-based dispersions, oil-based oil solutions, capsule suspensions (CS), dusts (DP), seed dressings, granules for broadcast and land application, granules (GR) in the form of micro-, spray, coating and adsorption granules, water-soluble granules (WG), water-soluble granules (SG), ULV formulations, microencapsulations and more. These individual formulation types are known in principle and are described, for example, in: Winnacker-Küchler, "Chemische Technologie", Volume 7, C. Hanser Verlag Munich, 4th ed. 1986, Wea van Valkenburg, "Pesticide Formulations", Marcel Dekker, NY, 1973, K. Martens, "Spray Drgy" in Handbook, 3rd ed. 1979, G. Goodwin Ltd. London.The necessary formulation aids such as inorganic materials, surfactants, solvents and other additives are also known and are described, for example, in: Watkins, "Handbook of Insecticide Dust Diluents and Carriers", 2nd Ed. and Dnd Books, Caldwell NJ, Hv Olphen, "Introduction to Clay Colloid Chemistry", 2nd Ed. J., Wiley & Sons, NY, C. Marsden, "Solvents Guide", 2nd Ed., Interscience, NY 1963, McCutcheon's "Drugs and Emulsifiers Annual", MC Publ. Corp., Ridgewood NJ, Sisley and Wood, "Encyclopedia of Chemical Active Agents", Chem. Publ. Co. Inc., NY 1964, Schönfeldt, "Grenzflächenaktive Äthylenoxiduakdte", Wiss. Verlagsgesell., Stuttgart 1976, Winnacker-Küchler, "Chemische Technologie", Volume C.7 H, anser Verlag Munich, 4th ed. 1986. Wettable powders are preparations that are evenly dispersible in water and which, in addition to the active ingredient, contain a diluent or inert substance as well as ionic and / or non-ionic surfactants (wetting agents, dispersants), e.g.polyoxyethylated alkylphenols, polyoxyethylated fatty alcohols, polyoxyethylated fatty amines, fatty alcohol polyglycol ether sulfates, alkylsulfonates, alkylbenzenesulfonates, sodium ligninsulfonic acid, sodium 2,2'-dinaphthylmethane-6,6'-disulfonic acid, sodium dibutylnaphthalenesulfonic acid or sodium oleoylmethyltaurine. To manufacture the wettable powders, the herbicidal active ingredients are, for example, processed in conventional equipment such as hammer mills, blower mills and BCS231018 abroad -. 11- Finely ground in air jet mills and simultaneously or subsequently mixed with the formulation aids. Emulsifiable concentrates are produced by dissolving the active ingredient in an organic solvent, e.g., butanol, cyclohexanone, dimethylformamide, xylene, or higher-boiling aromatics or hydrocarbons, or mixtures of organic solvents, with the addition of one or more ionic and / or non-ionic surfactants (emulsifiers). Examples of emulsifiers that can be used are: alkylaryl polyglycol esters, calcium salts such as Ca-dodecylbenzenesulfonate, or non-ionic emulsifiers such as fatty acid polyglycol esters, alkylaryl polyglycol ethers, fatty alcohol polyglycol ethers, propylene oxide-ethylene oxide condensation products, sorbitan esters such as sorbitan fatty acid esters or polyoxyethylene sorbitan fatty acid esters. Dusting agents are obtained by grinding the dust with finely divided solid substances, e.g.Tamok, natural clays, such as kaolin, bentonite, and pyrolytic clay, or diatomaceous earth. Suspension concentrates can be produced on water or oil. They can be produced, for example, by wet grinding using commercially available bead mills and, if appropriate, with the addition of surfactants, as listed above for the other formulation types. Emulsions, e.g., oil-in-water emulsions (EW), can be produced, for example, using stirrers, colloid mills, and / or static mixers using aqueous organic solvents and, if appropriate, surfactants, as listed above for the other formulation types. Granules can be produced either by spraying the substance onto adsorptive, granulated inert material or by applying active ingredient concentrates using adhesives, e.g.,Polyvinyl alcohol, sodium polyacrylate, or mineral oils, onto the surface of carrier materials such as sand, kaolinite, or granular inert material. Suitable active ingredients can also be granulated in the manner customary for the production of fertilizer granules—if desired, mixed with fertilizers. Water-dispersible granules are produced by conventional processes such as spray drying, fluidized-bed granulation, disc granulation, mixing with high-speed mixers, and extrusion without solid inert material. For the production of disc, fluidized-bed, extruded, and spray granules, see, for example, the processes in "Spray-Drying Handbook," 3rd ed. 1979, G. Goodwind. L,t London, JE Browning, "Agglomeration", Chemical and Engineering 1967, pages 147 ff, "yP'serr Chemical Engineer's Handbook", 5th Ed., McGraw-Hill, New York 1973, pp.8-57. BCS231018 Abroad -. 12For further details on the formulation of plant protection agents, see, for example, GC Klingman, "Weed Control as a Science", John Wiley and Sons, Incorporated, New York, 1961, pages 81-96 and JD Freyer, SA Evans, "Weed Control Handbook", 5th Ed., Blackwell Scientific Publications, Oxford, 1968, pages 101-103. The agrochemical preparations contain, in general, 0.1 to 99% by weight, in particular 0.1 to 95% by weight, of compounds according to the invention. In wettable powders, the active ingredient concentration is, for example, about 10 to 90% by weight, the remainder to 100% by weight consisting of conventional formulation ingredients. In emulsifiable concentrates, the active ingredient concentration can be about 1 to 90, preferably 58 to 80% by weight. Dust-like formulations contain 1 to 30 wt.% active ingredient, preferably up to 520 wt.% active ingredient, sprayable solutions contain about 0.05 to 80, preferably 2 to 50 wt.% active ingredient.In water-dispersible granules, the active ingredient content depends partly on whether the active compound is liquid or solid and which granulation aids, fillers, etc. are used. For water-dispersible granules, the active ingredient content is, for example, between 1 and 95% by weight, preferably between 10 and 80% by weight. In addition, the active ingredient formulations mentioned may contain the usual adhesives, wetting agents, dispersants, emulsifiers, penetration agents, grain dispersants, antifreeze agents, solvents, fillers, carriers, dyes, defoamers, evaporation inhibitors, and pH and viscosity-influencing agents. On the basis of these formulations, combinations can be produced with other pesticidally active substances, such as insecticides, acaricides, herbicides, fungicides, as well as with safeners, fertilizers and / or growth regulators, e.g. in the form of a ready-made formulation or as a tank mix.For use, the formulations in commercially available form are diluted, if necessary, in the customary manner, e.g. in the case of wettable powders, dispersible concentrates, dispersions and water-dispersible granules, using water. Formulated preparations, soil or broadcast granules and sprayable solutions are not normally diluted with other inert substances before use. The required application rate of the compounds of formula (I) varies with external conditions such as temperature, humidity, the type of herbicide used, etc. It can vary within wide limits, e.g. between 0.001 and 1.0 g / ha more active substance, but is preferably between 0.005 and 750 g / ha. The compounds of formula (I) according to the invention can also be used as required in mixtures with other BCS231018 abroad -. 13- herbicides. Suitable combination ingredients for the compounds of formula (I) in mixture formulations or in tank mixes include, for example, known active ingredients which are based on the inhibition of, for example, acetolactate synthase, acetyl-CoA carboxylase, cellulose synthase, enolpyruvylshikimate 3-phosphate synthase, glutamyl esterase, p-hydroxyphenylpyruvate dioxygenase, phytoene desaturase, photosystem I, pyhsotem II, protoporphyrinogen oxidase, or which act as plant growth regulators, for example from Weed Research 26 (1986) 441-445 or "The Pesticide Manual", 14th edition, The British Crop Protection Council and the Royal Society. of Chemistry, 2006 and the literature cited therein. Known herbicides or plant growth retardants that can be combined with compounds of formula (I) includeFor example, the following outputs are to be mentioned (the compounds are designated either by the "common name" according to the International Organization for Standardization (ISO) or by the chemical name or by the code number). This always includes all application forms such as acids, salts, esters and isomers, including stereoisomers and optical isomers. Examples of one or sometimes multiple application forms are mentioned: Acetochlor, Acifluorfen, Acifluorfen-methyl, Acifluorfen-sodium, Aclonifen, Alachlor, Allidochlor, Alloxydim, Alloxydim-sodium, Ametryn, Amicarbazon, Amidochlor, Amidosulfuron, 4-Amino-3-chloro-6-(4-chloro-2-fluoro-3-methylphenyl)-5-fluoropiydrin-2-carboxylic acid, Aminocyclopyrachlor, Aminocyclopyrachlor-potassium, Aminocyclopyrachlor-methyl, Aminopyralid, Aminopyralid-dimethylammonium, Aminopyralid-tripromine, Amitrol, Ammonium sulfamate, Anilofos, Asulam, Asulam-potassium, Asulam-sodium, Atrazine, Azafenidine, Azimsulfuron, Beflubutamide, (S)-(-)-Beflubutamide, Beflubutamide-M,Benazolin, Benazoelitnh-yl, Benazolin-dimethylammonium, Benazolin- Klaium, Benfluralin, Benfuresate, Bensulfuron, Buelnfusron-methyl, Bensulid, Bentazon, Bentazon- Natrium, Benzobicyclon, Benzofenap, Bicyclopyrone B,ifenox, Bilanafos, Bilanafos-Natium, Bipyrazone, Bispyribac, Bispyribac-Natium, Bixloz,o Bnromacil, Bromacil-lithium, Bromacil-Natrium, Bromobutid, Bromofenoxim, Bromoxynil, Bromoxynilbyurtat, Bromoxynil-Kalium, Bromoxynil- heptanoat und Bromoxynil-octanoat, Busoxinon, Bhultoarc, Butafenacil, Butamifos, Butenachlor, Butralin, Butroxydim, Butylat, Cafenstrol, Cambecnhdlior, Carbetamide, Carfentrazon, Carfentrazon- Ethyl, Chloramben, Chloramben-ammonium, Chloramdbieonla-min, Chlroamben-methyl, Chloramben- methylammonium, Chloramben-Natium, Chlorbromuron,hlo Crfenac, Chlorfenac-ammonium, Chlorfenac-Natium, Chlorfenprop, Chlorfenprop-mel,thy Chlorflurenol, Chlorflurenol-methyl, Chloridazon, Chlorimuron, Chlorimuron-ethyl, Chloprhothalim, Chlorotoluron, Chlorsulfuron, Chlorthal,Chlorthal-dimethyl, Chlorthal-monomethyl, Cinido Cni,nidon-ethyl, Cinmethylin, exo-(+)-Cinmethylin, d.h. (1R,2S,4S)-4-isopropyl-1-methyl-2-[(2-methynlbzeyl)oxy]-7-oxabicyclo[2.2.1]heptan, exo-(-)-Cinmethylin, d.h. (1R,2S,4S)-4-isopropyl-1-methy-[l(-2 -methylbenzyl)oxy]-7-oxabicyclo[2.2.1]heptan,Cinosulfuron, Clacyfos, Clethodim, Clodinafop, Cilnoadfop-ethyl, Clodinafop-propargyl, Clomazon, Clomeprop, Clopyralid, Clopyralid-methyl, Clopyrda-loilamin, Clopyralid-Kalium, Clopyralid-tripomin, Cloransulam, Cloransulam-methyl, Cumyluron, Cyandaem, i Cyanazine, Cycloat, Cyclopyranil, BCS231018 Ausland -, 14- Cyclopyrimorat, Cyclosulfamuron, Cycloxydim, Cyhfaolop, Cyhalofop-butyl, Cyprazin, 2,4-D (sowie die Ammonium, Butotyl, Butyl, Cholin, Diethylammonium D,imethylammonium, Diolamin, Doboxyl, Dodecylammonium, Etexyl, Ethyl, 2-Ethylhexyl, Helpatmymonium, Isobutyl, Isooctyl, Isopropyl, Isopropylammonium, Lithium, Meptyl, Methyl, Kalium T,etradecylammonium, Triethylammonium, Triisopropanolammonium, Tripromin and Trolamin Sealz davon), 2,4-DB, 2,4-DB-butyl, 2,4-DB- Dimethylammonium, 2,4-DB-isooctyl, 2,4-DB-Kalium d un 2,4-DB-Natrium, Daimuron (Dymron), Dalapon, Dalapon-Calcium, Dalapon-Magnesium, Danla-Npoatium, Dazomet, Dazomet-Natrium, n- Decanol, 7-Deoxy-D-sedoheptulose, Desmedipham,s Dyel-ptoyrazolat (DTP), Dicamba und seine Salze (z.B. Dicamba-biproamin, Dicamba-N,N-Bis(3-aminopyrol)methylamin, Dicamba-butotyl, Dicamba- cholin, Dicamba-Diglycolamin, Dicamba-Dimethylammiuomn, Dicamba-Diethanolaminemmonium, Dicamba-Diethylammonium, Dicamba-isopropylammonium, Dicamba-methyl,Dicamba- monoethanolamin, Dicamba-olamin, Dicamba-Kalium,ca Dmiba-Natium, Dicamba-Triethanolamin), Dichlobenil, 2-(2,4-Dichlorbenzyl)-4,4-dimethyl-1-o,2xazolidin-3-on, 2-(2,5-Dichlorbenzyl)-4,4- dimethyl-1,2-oxazolidin-3-one, Dichlorprop, Dichplorrop-butotyl, Dichlorprop-Dimethylammonium, Dichhlorprop-etexyl, Dichlorprop-ethylammonium, Dhilcorprop-isoctyl, Dichlorprop-methyl, Dichlorprop-Kalium, Dichlorprop-Natrium, Dichlorppro-P, Dichlorprop-P-Dimethylammonium, Dichlorprop-P-etexyl, Dichlorprop-P-Kalium, Dichlporrop-Natrium, Diclofop, Diclofop-methyl, Diclofop-P, Diclofop-P-methyl, Diclosulam, Difenzuoaqt, Difenzoquat-metilsulfate, Diflufenican, Diflufenzopyr, Diflufenzopyr-Natrium, Dimefuron, Dmiepiperate, Dimesulfazet, Dimethachlor, Dimethametryn, Dimethenamid, Dimethenamid-P, Dimaseutrlfuron, Dinitramine, Dinoterb, Dinoterb- Acetate, Diphenamid, Diquat, Diquat-Dibromid, Diqt-uDaichloride, Dithiopyr, Diuron, DNOC, DNOC- Ammonium, DNOC-Kalium, DNOC-Natrium, Endothal,Enthdaol-Diammonium, Endothal-Dikalium, Endothal-Dinatrium, Epyrifenacil (S-3100), EPTC,p Eroscarb, Ethalfluralin, Ethametsulfuron, Ethamet- sulfuron-Methyl, Ethiozin, Ethofumesate, Ethoxyfe Enth,oxyfen-Ethyl, Ethoxysulfuron, Etobenzanid, F- 5231, d.h. N-[2-Chlor-4-fluor-5-[4-(3-fluorpropyl4)-,5-dihydro-5-oxo-1H-tetrazol-1-yl]-phenyl]- ethansulfonamid, F-7967, i.e. 3-[7-Chlor-5-fluor(-t2ri-fluormethyl)-1H-benzimidazol-4-yl]-1-methyl-6- (trifluormethyl)pyrimidin-2,4(1H,3H)-dion, Fenoxaoppr, Fenoxaprop-P, Fenoxaprop-Ethyl, Fenoxaprop-P-Ethyl, Fenoxasulfone, Fenpyrazone, Fenquinot,rio Fne ntrazamid, Flamprop, Flamprop-Isoproyl,Flamprop-Methyl, Flamprop-M-Isopropyl, Flamprop-Me-Mthyl, Flazasulfuron, Florasulam, Florpyrauxifen, Florpyrauxifen-benzyl, Fluazifop,lu Fazifop-Butyl, Fluazifop-Methyl, Fluazifop-P, Fluazifop-P-Butyl, Flucarbazone, Flucarbazone-Nuamtr,i Flucetosulfuron, Fluchloralin, Flufenacet, Flufenpyr, Flufenpyr-Ethyl, Flumetsulam, Flumiclocr,a Flumiclorac-Pentyl, Flumioxazin,Fluometuron, Flurenol, Flurenol-Butyl, -Dimethylammonium and -Methyl, Fluoroglycofen, Fluoroglycofen-Ethyl, Flupropanat, Flupropanat-Natrium, Flupyrsulfuronl,up Fyrsulfuron-Methyl, Flupyrsulfuron-Methyl- Natrium, Fluridon, Flurochloridon, Fluroxypyr, Foluxrypyr-Butomethyl, Fluroxypyr-Meptyl, Flurtamon, Fluthiacet, Fluthiacet-Methyl, Fomesafen, Fomes-aNfeantrium, Foramsulfuron, Foramsulfuron-Natrium, Fosamine, Fosamine-Ammonium, Glufosinate, Glufos-Ainmatmonium, Glufosinate-Natrium, L- Glufosinate-Ammonium, L- Glufosinate-Natrium, Glufosaitn-P-Natrium, Glufosinate-P-Ammonium, BCS231018 Ausland -, 15- Glyphosat, Glyphosat-Ammonium, Glyphosat-Isoprompymlaonium, Glyphosat-Diammonium, Glyphosat-Dimethylammonium, Glyphosat-Kalium, Glyopshat-Natrium, Glyphosat-Sesquinatrium und Glyphosat-Trimesium, H-9201, d.h. O-(2,4-Dimethy-nl-i6trophenyl)-O-ethyl- isopropylphosphoramidothioat, Halauxifen, Halaunx-ifmeethyl, Halosafen, Halosulfuron, Halosulfuron- Methyl, Haloxyfop, Haloxyfop-P, Haloxyfop-Ethoxyeytlh, Haloxyfop-P-Ethoxyethyl, Haloxyfop- Methyl, Haloxyfop-P-Methyl, Haloxifop-Natrium, Hezxainon, HNPC-A8169, i.e. Prop-2-yn-1-yl (2S)-2- {3-[(5-tert-butylpyridin-2-yl)oxy]phenoxy}propano,at HW-02, d.h. 1-(Dimethoxyphosphoryl)-ethyl- (2,4-dichlorphenoxy)acetat, Hydantocidin, Imazamaebtehnz, Imazamethabenz-Methyl, Imazamox, Imazamox-Ammonium, Imazapic, Imazapic-Ammonium, z Imapayr, Imazapyr-Isopropylammonium, Imazaquin, Imazaquin-Ammonium, Imazaquin-Methyl, a Izmethapyr, Imazethapyr-Ammonium, Imazosulfuron, Indanofan, Indaziflam, Iodosulfuron Io,dosulfuron-Methyl, Iodosulfuron-Methyl- Natrium,Ioxynil, Ioxynil-Lithium, -Octanoat, -Kaulim und Natrium, Ipfencarbazon, Isoproturon, Isou,ron Isoxaben, Isoxaflutole, Karbutilat, KUH-043, d.h-.({ 3[5-(Difluormethyl)-1-methyl-3-(trifluormethyl)- 1H-pyrazol-4-yl]methyl}sulfonyl)-5,5-dimethyl-4,5-ihdydro-1,2-oxazol, Ketospiradox, Ketospiradox- Kalium, Lactofen, Lenacil, Linuron, MCPA, MCPA-Butytol, -Butyl, -Dimethylammonium, -Diolamin, - 2-Ethylhexyl, -Ethyl, -Isobutyl, Isoctyl, -Isoprolp,y -Isopropylammonium, -Methyl, Olamin, -Kalium, – Natrium und -Trolamin, MCPB, MCPB-Methyl, -Ethyl d un -Natrium, Mecoprop, Mecoprop-Butotyl, Mecoprop- dimethylammonium, Mecoprop-Diolamin, Mpercoop-Etexyl, Mecoprop-Ethadyl, Mecoprop- Isoctyl, Mecoprop-Methyl, Mecoprop-Kalium, Mecopr-oNpatrium, und Mecoprop-Trolamin, Mecoprop- P, Mecoprop-P-Butotyl, -Dimethylammonium, -2-Etheyxlhyl und -Kalium, Mefenacet, Mefluidid, Mefluidid-Diolamin, Mefluidid-Kalium, Mesosulfuron M, esosulfuron-Methyl, Mesosulfuron-Natrium, Mesotrion, Methabenzthiazuron, Metam,Metamifop, ta Mmeitron, Metazachlor, Metazosulfuron, Methabenzthiazuron, Methiopyrsulfuron, Methiozolin M, ethyl isothiocyanat, Metobromuron, Metolachlor, S-Metolachlor, Metosulam, Metoxuron,et Mribuzin, Metsulfuron, Metsulfuron-Methyl, Molinat, Monolinuron, Monosulfuron, Monosulfuron-Mtheyl, MT-5950, d.h. N-[3-Chlor-4-(1- methylethyl)-phenyl]-2-methylpentanamid, NGGC-011, Napropamid, NC-310, i.e. 4-(2,4- Dichlorbenzoyl)-1-methyl-5-benzyloxypyrazol, NC-6,56 i.e. 3-[(Isopropylsulfonyl)methyl]-N-(5- methyl-1,3,4-oxadiazol-2-yl)-5-(trifluormethyl)[1,,42]triazolo-[4,3-a]pyridin-8-carboxamid, Neburon, Nicosulfuron, Nonansäure (Pelargonsäure), Norflounra,z Ölsäure (Fettsäuren), Orbencarb, Orthosulfamuron, Oryzalin, Oxadiargyl, Oxadiazon,xa Osulfuron, Oxaziclomefone, Oxyfluorfen, Paraquat, Paraquat-dichlorid, Paraquat-Dimethyalst,ulf Pebulat, Pendimethalin, Penoxsulam, Pentachlorphenol, Pentoxazon, Pethoxamid, Petroölle,um Phenmedipham, Phenmedipham-Ethyl, Picloram, Picloram-dimethylammonium,Picloram-Etle,x Pyicloram-Isoctyl, Picloram-Methyl, Picloram- Olamin, Picloram-Kalium, Picloram-Triethylammonium P,icloram-Tripromin, Picloram-Trolamin, Picolinafen, Pinoxaden, Piperophos, Pretilachlorri,mi Psulfuron, Primisulfuron-Methyl, Prodiamine, Profoxydim, Prometon, Prometryn, Propachlor, Proil,pa Pnropaquizafop, Propazine, Propham, Prop- isochlor, Propoxycarbazone, Propoxycarbazone-Nma,tri Puropyrisulfuron, Propyzamid, Prosulfocarb, Prosulfuron, Pyraclonil, Pyraflufen, Pyraflufen-Eylt,h Pyrasulfotol, Pyrazolynat (Pyrazolat), Pyrazo- BCS231018 Ausland -, 16- sulfuron, Pyrazosulfuron-Ethyl, Pyrazoxyfen, Pymribbaenz, Pyribambenz-Isopropyl, Pyribambenz- Propyl, Pyribenzoxim, Pyributicarb, Pyridafol, Pdyarti, Pyriftalid, Pyriminobac, Pyriminobac-Methyl, Pyrimisulfan, Pyrithiobac, Pyrithiobac-Natrium, Poxyrasulfon, Pyroxsulam, Quinclorac, Quinclorac- Dimethylammonium, Quinclorac-Methyl, Quinmerac, Qnoucilamin, Quizalofop, Quizalofop-Ethyl, Quizalofop-P, Quizalofop-P-Ethyl, Quizalofop-P-Treyflu, QYM201, i.e. 1-{2-Chlor-3-[(3-cyclopropyl- 5-hydroxy-1-methyl-1H-pyrazol-4-yl)carbonyl]-6-(ftlruiormethyl)phe-nyl}piperidin-2-on, Rimsulfuron, Saflufenacil, Sethoxydim, Siduron, Simazine, Simyne,tr SL-261, Sulcotrione, Sulfentrazone, Sulfo- meturon, Sulfometuron-Methyl, Sulfosulfuron, , SY2P49-, d.h. 1-Ethoxy-3-methyl-1-oxobut-3-en-2-yl- 5-[2-chlor-4-(trifluormethyl)phenoxy]-2-nitrobenzto,a SYP-300, i.e. 1-[7-Fluor-3-oxo-4-(prop-2-in-1- yl)-3,4-dihydro-2H-1,4-benzoxazin-6-yl]-3-propyl-t2h-ioxoimidazolidin-4,5-dion, 2,3,6-TBA,TCA (Trichloressigsäure) und seine Salze, z.B. TCA-amniummo, TCA-Calcium, TCA-Ethyl, TCA- Magnesium, TCA-Natrium, Tebuthiuron, Tefuryltrion Tee,mbotrion, Tepraloxydim, Terbacil, Terbucarb, Terbumeton, Terbuthylazine, Terbutryn, Tetflupymroelit, Thaxtomin, Thenylchlor, Thiazopyr, Thien- carbazone, Thiencarbazon-Methyl, Thifensulfuron,ife Tnhsulfuron-Methyl, Thiobencarb, Tiafenacil, Tolpyralat, Topramezon, Tralkoxydim, Triafamon, - Tarlliat, Triasulfuron, Triaziflam, Tribenuron, Tribenuron-Methyl, Triclopyr, Triclopyr-Butotyl, Ticrlopyr-Cholin, Triclopyr-Ethyl, Triclopyr- Triethylammonium, Trietazine, Trifloxysulfuron, Tflroixysulfuron-Natrium, Trifludimoxazin, Triflurali,n Triflusulfuron, Triflusulfuron-Methyl, Tritosulfuron, Harnstoffsulfat, Vernolat, XDE-848, ZJ-0862,. d.h 3,4-Dichlor-N-{2-[(4,6-dimethoxypyrimidin-2-yl)oxyb]enzyl}anilin, 3-(2-Chlor-4-fluor-5-(3-methyl- 2,6-dioxo-4-trifluormethyl-3,6-dihydropyrimidin-1(H2)-yl)phenyl)-5-methyl-4,5-dihydroisoxazole-5- carbonsäureethylester, Ethyl-[(3-{2-chlor-4-fluo-r[-35-methyl-2,6-dioxo-4-(trifluormethyl)-3,6- dihydropyrimidin-1(2H)-yl]phenoxy}pyridin-2-yl)oxya]cetat, 3-Chlor-2-[3-(difluormethyl)isoxazolyl-5- yl]phenyl-5-chlorpyrimidin-2-ylether, 2-(3,4-Dimeothxyphenyl)-4-[(2-hydroxy-6-oxocyclohex-1-en-1- yl)carbonyl]-6-methylpyridazine-32(H)-on, 2-({2-[(2-Methoxyethoxy)methyl]-6-methylpyriind-3- yl}carbonyl)cyclohexan-1,3-dion, (5-Hydroxy-1-metlh-1yH-pyrazol-4-yl)(3,3,4-trimethyl-1,1-dioxido- 2,3-dihydro-1-benzothiophen-5-yl)methanon, 1-Me-t4h-y[l(3,3,4-trimethyl-1,1-dioxido-2,3-dihydro-1- benzothiophen-5-yl)carbonyl]-1H-pyrazol-5-yl prop-1a-nsulfonat, 4-{2-Chlor-3-[(3,5-dimethyl-1H- pyrazol-1-yl)methyl]-4-(methylsulfonyl)benzoyl}-1-emthyl-1H-pyrazol-5-yl-1,3-dimethyl-1H-pyrazol- 4-carboxylat; Cyanomethyl-4-amino-3-chlor-5-fluo-r(-76-fluor-1H-indol-6-yl)pyridin-2-carboxylat, Prop-2-yn-1-yl 4-amino-3-chlor-5-fluor-6-(7-fluorH-1-indol-6-yl)pyridin-2-carboxylat,Methyl-4-amino- 3-chlor-5-fluor-6-(7-fluor-1H-indol-6-yl)pyridin-2c-arboxylat, 4-Amino-3-chlor-5-fluor-6-(7-fluor-1H- indol-6-yl)pyridin-2-carbonsäure, Benzyl-4-aminoc-h3l-or-5-fluor-6-(7-fluor-1H-indol-6-yl)pyridin-2- carboxylat, Ethyl-4-amino-3-chlor-5-fluor-6-(7-flur-o1H-indol-6-yl)pyridin-2-carboxylat, Methyl-4- amino-3-chlor-5-fluor-6-(7-fluor-1-isobutyryl-1H-dinol-6-yl)pyridin-2-carboxylat, Methyl 6-(1-acetyl--7 fluor-1H-indol-6-yl)-4-amino-3-chlor-5-fluorpyridi-n2-carboxylat, Methyl-4-amino-3-chlor-6-[1-(2,2- dimethylpropanoyl)-7-fluor-1H-indol-6-yl]-5-fluorpryidin-2-carboxylat, Methyl-4-amino-3-chlor-5- fluor-6-[7-fluor-1-(methoxyacetyl)-1H-indol-6-yl]pryidin-2-carboxylat, Kalium 4-amino-3-chlor-5- fluor-6-(7-fluor-1H-indol-6-yl)pyridin-2-carboxyla,t Natrium-4-amino-3-chlor-5-fluor-6-(7-fluor-1H- BCS231018 Ausland -, 17- indol-6-yl)pyridin-2-carboxylat, Butyl-4-amino-3-clohr-5-fluoro-6-(7-fluoro-1H-indol-6-yl)pyridin-2- carboxylat, 4-Hydroxy-1-methyl-3-[4-(trifluoromethl)pyyridin-2-yl]imidazolidin-2-on, 3-(5-tert-butyl- 1,2-oxazol-3-yl)-4-hydroxy-1-methylimidazolidin-2n-o, 3-[5-Chlor-4-(trifluormethyl)pyridin-2-yl]-4- hydroxy-1-methylimidazolidin-2-on, 4-Hydroxy-1-meotxhy-5-methyl-3-[4-(trifluormethyl)pyridin-2- yl]imidazolidin-2-on, 6-[(2-Hydroxy-6-oxocyclohex-e1n-1-yl)carbonyl]-1,5-dimethyl-3-(2- methylphenyl)chinazolin-2,4(1H,3H)-dion, 3-(2,6-Deimthylphenyl)-6-[(2-hydroxy-6-oxocyclohex-1-en- 1-yl)carbonyl]-1-methylchinazolin-2,4(1H,3H)-dion, 2-[2-chlor-4-(methylsulfonyl)-3-(morpholin-4- ylmethyl)benzoyl]-3-hydroxycyclohex-2-en-1-on, 1--c(2arboxyethyl)-4-(pyrimidin-2-yl)pyridazin-1- iumsalz (mit passenden Anionen wie z.B Chlorid, t Aacte oder Trifluoracetat), 1-(2-Carboxyethyl)-4- (pyridazin-3-yl)pyridazin-1-iumsalz (mit passende Annionen wie z.B. Chlorid, Acetat oder Trifluoracetat),4-(Pyrimidin-2-yl)-1-(2-sulfoethyl)pyridazin-1-ium salt (with suitable anions such as chloride, acetate or trifluoroacetate), 4-(pyrimidin-3-yl)-1-(2-sulfoethyl)pyridazin-1-ium salt (with suitable anions such as chloride, acetate or trifluoroacetate), 1-(2-carboxyethyl)-4-(1,3-thiazol-2-yl)pyridazin-1-ium salt (with suitable anions such as chloride, acetate or trifluoroacetate), 1-(2-carboxyethyl)-4-(1,3,4-thiadiazol-2-yl)pyridazin-1-ium salt (with suitable anions such as chloride, acetate or trifluoroacetate), methyl (2R)-2-{[(E)-2({-chloro-4-fluoro-5-[3-methyl-2,6-dioxo-4-(trifluoromethyl)-3,6-dihydropyrimidin-1(2H)-yl]pheynl}methylidene)amino]oxy}propanoate, methyl (2S)- Methyl dioxo-4-(trifluoromethyl)-3,6-dihydropyrimidine-1(2H-y)l]phenyl}methylidene)amino]oxy}propanoate,(E)- 2-(Trifluormethyl)benzaldehyd-O-{2,6-bis[(4,6-dimheotxypyrimidin-2-yl)oxy]benzoyl}oxim, 2-Fluor- N-(5-methyl-1,3,4-oxadiazol-2-yl)-3-[(R)-propylsuinlfyl]-4-(trifluormethyl)benzamid, (2R)-2-[(4- Amino-3,5-dichlor-6-fluor-2-pyridyl)oxy]propancarbnosäure, 2-Ethoxy-2-oxoethyl-1-{2-chlor-4-fluor- 5-[3-methyl-2,6-dioxo-4-(trifluormethyl)-3,6-dihydorpyrimidin-1(2H)- yl]phenoxy}cyclopropancarboxylat, 2-Methoxy-2-oxhoyelt-1-{2-chlor-4-fluor-5-[3-methyl-2,6-dioxo-4- (trifluormethyl)-3,6-dihydropyrimidin-1(2H)-yl]pheonxy}cyclopropancarboxylat, {[(1-{2-Chlor-4-fluor- 5-[3-methyl-2,6-dioxo-4-(trifluormethyl)-3,6-dihydorpyrimidin-1(2H)- yl]phenoxy}cyclopropyl)carbonyl]oxy}essigsäure, 2-B( rom-4-chlorbenzyl)-4,4-dimethyl-1,2- oxazolidin-3-on, Methyl 3-{2-chlor-4-fluor-5-[3-mheytl-2,6-dioxo-4-(trifluoromethyl)-3,6- dihydropyrimidin-1(2H)-yl]phenyl}-3a,4,5,6-tetrahyrod-6aH-cyclopenta[d][1,2]oxazol-6a-carboxylat, Ethyl 3-{2-chlor-4-fluor-5-[3-methyl-2,6-dioxo-4-r(itfluoromethyl)-3,6-dihydropyrimidin-1(2H)- yl]phenyl}-3a,4,5,6-tetrahydro-6aH-cyclopenta[d]2[1]o,xazol-6a-carboxylat.Abscisinsäure und verwandte Analoga [z.B. (2Z,4-E[6)-5 Ethynyl-1-hydroxy-2,6-dimethyl-4-oxocyclohex-2-en-1-yl]-3-methylpenta-2,4-diensäure, methyl-(2Z,4E)-5-[6-ethynyl-1-hydroxy-2,6- dimethyl-4-oxocyclohex-2-en-1-yl]-3-methylpenta--2d,i4enoat, (2Z,4E)-3-ethyl-5-(1-hydroxy-2,6,6- trimethyl-4-oxocyclohex-2-en-1-yl)penta-2,4-dienrseä,u (2E,4E)-5-(1-hydroxy-2,6,6-trimethyl-4- oxocyclohex-2-en-1-yl)-3-(trifluoromethyl)penta-2-d,4iensäure, methyl (2E,4E)-5-(1-hydroxy-2,6,6- trimethyl-4-oxocyclohex-2-en-1-yl)-3-(trifluoromeythl)penta-2,4-dienoat, (2Z,4E)-5-(2-hydroxy-1,3- BCS231018 Ausland -, 18- dimethyl-5-oxobicyclo[4.1.0]hept-3-en-2-yl)-3-methylphenyl-2,4-dienoic acid], Acibenzolar, Acibenzolar-S-methyl, S-adenosylhomocysteine, Allantoin, 2-aminoextyvinylglycine (AVG), aminooxyacetic acid and related esters [e.g. (isopropylidene)-aminooxyacetate 2-(methoxy)-2-oxoethyl ester, (isopropylidene)-aminooxyacetate 2-(hexyloxy)-2-oxoethyl ester, (cyclohexylidene)-aminooxyacetate 2-(isopropyloxy)-2-oxoethyl ester], ste 1r-Aminocycloprop-1-ylcarboxylic acid N-methyl- 1-aminocyclopropyl-1-carboxylic acid, 1-Aminocyclopropyl-1-carboxylic acid amide, substituted 1-aminocyclopropyl-1-carboxylic acid derivatives as described in D335514, EP30287, DE2906507 or US5123951, 1-aminocyclopropyl-1-hydroxaumres, 5-aminolevulinic acid, ancymidol, 6-benzylaminopurine, bikinin, brassinolide, brassinoeli-dethyl, L-canalin, catechin and catechins (e.g.(2S,3R)-2-(3,4-Dihydroxyphenyl)-3,4-dihydro-2H-chloroene-3,5,7-triol), chitooligosaccharides (CO; COs differ from LCOs in that they have fatty acid side chains characteristic of LCOs. LCOs, sometimes referred to as N-acetylchitooligosaccharides, are also made up of GlcNAc units, but have side chains that distinguish them from chitin molecules8[H(C 13 NO5) n , CAS No. 1398-61-4] and chitosan molecules5[H(C 11 NO4) n, CAS No. 9012-76-4]), chitin-like compounds, chlormequat chloride, cloprop, cyclopropene, 3-(cycloprop-1-enyl)propionic acid, 1-[2-(4-cyano-3,5-dicyclopropylphenyl)acetamido]cyclohexanecarboxylic acid, 1-[2-(4-cyano-3-cyclopropylphenyl)acetamido]cyclohexanecarboxylic acid, cyclopropenylmethanol, daminozide, dazomet, dazomet sodium, n-decanol, dikegulac, dikegulac-nitroammonium, endothal, endothal-di-potassium, -di-sodium, and mono(N,N-dimethylalkylammonium), ethelopne, 1-ethylcyclopropene, flumetralin, flurenol, flurenol-butyl, flurenol-methyl, flurpridmol, Forchlorfenuron, gibberellic acid, inabenfid, indole-3-acetic acid (IAA), 4-indol-3-ylbutyric acid, isoprothiolane, probenazole, jasmonic acid, jasmonic acid esters or other derivatives (e.g., jasmonic acid ethyl ester, jasmonic acid ethyl ester), lipochitooligosaccharides (LCO, in some cases referred to as symbiotic nodulation signals (Nod or Nod factors) or Myc factors), which consist of an oligosaccharide backbone of β-l,4-linked N-acetyl-D-glucosamine residues (“GlcNAc”) with a Ne-linked fatty acid side chain fused to the non-reducing E. As can be seen from the literature, LCOs differ in the presence of GllcNAc units in the backbone structure, in the length and the degree of saturation of the fatty acid chain due to the substitution of the reducing and non-reducing sugar units), linoleic acid or its derivatives, linolenic acid or its derivatives, maleic acid hydrazide, mepiquat chloride, mepiquat pebnotrat, 1-methylcyclopropene, 3-methylcyclopropene, methoxyvinylglycine (MVG), 3'-methylabscisic acid, 1-(4-methylphenyl)-N-(2-oxo-1-propyl-1,2,3,4-tetrahydroquinolin-6-yl)methansulfonamide and related substituted (tetrahydroquinolin-6-yl)methanesulfonamides, (3E,3,8abRS)-3-({[(2R)-4-Methyl-5-oxo-2,5-dihydrofuran-2-yl]oxy}methylene)-3,3a,4,8b-tetrahyod-2rH-indeno[1,2-b]furan-2-one and related lactones as described in EP2248421,-N 2-a(p-methyl)acetamide,1-Naphthylacetic acid, 2-Naphthyloxyacetic acid, Nitrophenolate mixture, 4-O4[x(o2-phenylethyl)amino]butyric acid, Paclobutrazol, 4-Phenylbutyric acid and its salts, e.g. (Sodium 4-phenylbutanoate, Potassium 4-phenylbutanoate), Phenylalanine, N-Phenylphthalamres, Purohexadione, Prohexadione-Calcium, 1-n- BCS231018 Abroad -, 19- Propylcyclopropene, putrescine, prohydrojasmone, ribitizooxin, salicylic acid and salicyclic acid methyl ester, sarcosine, sodium cycloprop-1-en-1-yl acetate, sodium cycloprop-2-en-1-yl acetate, sodium 3-(cycloprop-2-en-1-yl)propanoate, sodium 3-(cycloprop-1-en-1)pyrolepanoate, sidefungin, spermidine, spermine, strigolactone, tecnazene, thidiazuron, triacont, torlinexapac, trinexapac-ethyl, tryptophan, tsitodef, uniconazole, uniconazole-P, 2-fluoro-N-(3e-tmhoxyphenyl)9-H-purin-6-amine. Although the compounds of the formula (I) according to the invention generally have good selectivity towards crop plants, it may be advantageous to combine them with known safeners. Safeners which, in combination with the compounds of the formula (I) according to the invention and optionally in combination with other active ingredients such as, for example,e inksicides, acaricides, herbicides, fungicides as listed above, are preferably selected from the group consisting of: S1) compounds of formula (S1), O. where the symbols and indices have the following meaning: nA is a natural number from 0 to 5, preferably 0 to 3; RA 1 is halogen, (C1-C4)alkyl, (C1-C4)alkoxy, nitro or (C1-C4)haloalkyl; W A is an unsubstituted or substituted derivative heterocyclic radical from the group of partially saturated or aromatic five-membered ring hexylenes with 1 to 3 hetero ring atoms from the group N and O, wherein at least one N atom and a maximum of one O atom is contained in the ring, preferably a radical from the group A (W 1 ) to (W A 5 ), m A is 0 or 1; R A 2 is OR A 3 , SR A 3 or NR A 3 R A 4or a saturated or unsaturated 3- or 7-membered heterocycle having at least one N-atom and up to 3 heteroatoms, preferably from the group O and S, which is connected to the carbonyl group in (S1) via the N-atom and is unsubstituted or substituted by radicals from the group (C1-C4)alkyl, (C1-C4)alkoxy or optionally substituted phenyl, BCS231018 Foreign countries - 20 - preferably a radical of the formula A O 3 ,R NHRA 4 or N(CH3)2, in particular of the formula OA 3 R; RA 3 is hydrogen or an unsubstituted or unsubstituted aliphatic hydrocarbon radical, preferably having a total of 1 to 18 C atoms; RA 4 is hydrogen, (C1-C6)alkyl, (C1-C6)alkoxy or substituted or unsubstituted pyl; RA 5 is H, (C1-C8)alkyl, (C1-C8)haloalkyl, (C1-C4)alkoxy(C1-C8)alkyl, cyano or COORA 9 , where RA 9is hydrogen, (C1-C8)alkyl, (C1-C8)haloalkyl, (C1-C4)alkoxy-(C1-C4)alkyl, (C1-C6)hydroxyalkyl, (C3-C12)cycloalkyl or tri-(C1-C4)alkylsilyl; R.A 6 , Attorney 7 , Attorney 8 are identical or different and are hydrogen, C(C8)alkyl, (C1-C8)haloalkyl, (C3-C12)cycloalkyl or substituted or unsubstituted phenyl; R A 10 is H, (C3-C 12 )Cycloalkyl, substituted or unsubstituted pyl or substituted or unsubstituted heteroaryl; preferably: a) compounds of the dichlorophenylpyrazo3li-nc-carboxylic acid type (S a )1, preferably compounds such as 1-(2,4-dichlorophenyl)-5-(ethoxycarbonyl)-5-methyl-2-pyrazole-3-carboxylic acid, 1-(2,4-dichlorophenyl)-5-(ethoxycarbonyl)-5-methyl-2-pyrazole-3-carboxylic acid ethyl ester (S1-1) ("Mefenpyr-diethyl"), and related compounds as described in WO-A-91 / 07874; b) derivatives of dichlorophenylpyrazolecarboxylic acid b) (,S1 preferably compounds such as 1-(2,4-dichlorophenyl)-5-methyl-pyrazole-3-carboxylic acid ethyl ester (S1-2), 1-(2,4-dichlorophenyl)-5-isopropyl-pyrazole-3-carboxylic acid ethyl ester (S1-3), 1-(2,4-dichlorophenyl)-5-(1,1-dimethyl-ethyl)pyrazole-3-carboxylic acid ethyl ester (S1-4) and related compounds as described in EP-A-333131 and EP-A-269806; c) derivatives of 1,5-diphenylpyrazole-3-carboxylic acid c ) (, preferably compounds such as 1-(2,4-dichlorophenyl)-5-phenylpyrazole-3-carboxylic acid threyl ester (S1-5), 1-(2-chlorophenyl)-5-phenylpyrazole-3-carboxylic acid methyl ester (S1-6) and related compounds as described, for example, in EP-A-268554; sd) compounds of the triazolecarboxylic acid type d) (,S1 preferably compounds such as fenchlorazole(ethyl ester), ie 1-(2,4-dichlorophle)-n5y-trichloromethyl-(1H)-1,2,4-triazole-3-carboxylic acid ethyl ester (S1-7), and related compounds as described in EP-A-174562 and EP-A-346620; e) compounds of the type of 5-benzyl- or 5-Ph-e2n-yisoxazoline-3-carboxylic acid or 5,5-diphenyl-2-isoxazoline-3-carboxylic acid ( e S),1 preferably connections like BCS231018 abroad - 21- 5-(2,4-Dichlorobenzyl)-2-isoxazoline-3-carboxylic acid ethyl ester (S1-8) or 5-phenyl-2-isoxazoline-3-carboxylic acid ethyl ester (S1-9) and related compounds as described in WO-A-91 / 08202, or 5,5-diphenyl-2-isoxazoline-3-carboxylic acid (S1)-10 or 5,5-diphenyl-2-isoxazoline-3-carboxylic acid ethyl ester (S1-11) ("Isoxadifen-ethyl"), the -n-propyl ester (S1-12) or the 5-(4-fluorophenyl)-5-phenyl-2-isoxazoline-3-carboxylic acid ethyl ester (S1-13) as described in patent application WO-A-95 / 07897. f) Compounds of the triazolyloxyacetic acid type (S1 f), preferably compounds such as methyl {[1,5-bis(4-chloro-2-fluorophenyl)-1H-1,2,4-triazol-3-yl]oxy}acetate (S1-14) or {[1,5-bis(4-chloro-2-fluorophenyl)-1H-1,2,4-triazol-3-yl]oxy}acetic acid (S1-15) or methyl {[5-(4-chloro-2-fluorophenyl)-1-(2,4-difluorophenyl)-1H-1,2,4-triazol-3-yl]oxy}acetate (S1-16) or {[5-(4-chloro-2-fluorophenyl)-1-(2,4-difluorophenyl)-1H-1,2,4-triazol-3-yl]oxy}acetic acid (S1-17) or methyl {[1-(4- chloro-2-fluorophenyl)-5-(2,4-difluorophenyl)-1H-1,2-,t4triazol-3-yl]oxy}acetate (S1-18) or {[1-(4-chloro-2-fluorophenyl)-5-(2,4-difluorophenyl)-1H-1,2,4-trioalz-3-yl]oxy}acetic acid (S1-19), as described in patent application WO2021105101 S2) Quinoline derivatives of the formula (S2), where the symbols and indices have the following meaning: RB 1 is halogen, (C1-C4)alkyl, (C1-C4)alkoxy, nitro or (C1-C4)haloalkyl; nB is a natural number from 0 to 5, preferably 3; RB 2 is ORB 3 , SRB 3 or NRB 3RB 4 or a saturated or unsaturated 3- to 7-membered heterocycle containing at least one N-atom and up to 3 heteroatoms, preferably from the group O and the S is bonded via the N-atom to the carbonyl group in (S2) and is unsubstituted or substituted by R from the group 1 (-C 4)alkyl, (C1-C4)alkoxy or optionally substituted phenyl, preferably a radical of the formula B O 3 ,R NHR B 4 or N(CH3)2, in particular of the formula O B 3 R; R B 3 is hydrogen or an unsubstituted or unsubstituted aliphatic hydrocarbon radical, preferably having a total of 1 to 18 C atoms; R B 4 is hydrogen, (C1-C6)alkyl, (C1-C6)alkoxy or substituted or unsubstituted pyl; BCS231018 Foreign countries - 22- TB is a (C1 or C2)-alkanediyl chain which is unsubstituted or substituted by one or two (C1-C4)alkyl radicals or by [(C1-C3)-alkoxy]carbonyl; preferably: a) compounds of the 8-quinolinoxyacetic acid type (S2 a), preferably (5-chloro-8-quinolinoxy)acetic acid-(1-methylhexyl)ester ("Cloquintocet-mexyl") (S2-1), (5-chloro-8-quinolinoxy)acetic acid-(1,3-dimethyl-but-1-yl)ester (S2-2), (5-chloro-8-quinolinoxy)acetic acid-4-allyloxy-butsytle r (S2-3), (5-chloro-8-quinolinoxy)acetic acid-1-allyloxy-prop-2-yl ester (S2-4), (5-chloro-8-quinolinoxy)acetic acid-ethyl ester (S2-5), (5-chloro-8-quinolinoxy)acetic acid methyl ester (S2-6), (5-chloro-8-quinolinoxy)acetic acid allyl ester (S2-7), (5-chloro 8-quinolinoxy)acetic acid 2-(2-propylidene-iminoxy-)ethyl ester (S2-8), (5-chloro-8-quinolinoxy)acetic acid 2-oxo-prop-1-yl ester (S2-9 and) and related compounds as described in EP-A-86750, EP-A-94349 and EP-A-191736 or E-PO-4A92366, and (5-chloro-8-quinolinoxy)acetic acid (S2-10), the hydrates of which, for example the lithium, sodium, potassium, calcium, magnesium, aluminum, iron, ammonium, quaternary ammonium, sulfonium,or phosphonium salts as described in WO-A-2002 / 384 b0e4; b) compounds of the type (5-chloro-8-quinolinoxy)alonic acid (S, b 2), preferably compounds such as (5-chloro-8-quinolinoxy)malonic acid ethyl ester, (5-chloro-8-quinolinoxy)malonic acid diallyl ester, C (5h-lor-8-quinolinoxy)malonic acid methyl ethyl ester and related compounds as described in EP-A-059882 b 1e.S3) Compounds of the formula (S3) O where the symbols and indices R C 1 is (C1-C4)alkyl, (C1-C4)haloalkyl, (C2-C4)alkenyl, (C2-C4)haloalkenyl, (C3-C7)cycloalkyl, preferably dichloromethyl; R C 2 , R C 3are the same or different hydrogen, C (C4)alkyl, (C2-C4)alkenyl, (C2-C4)alkynyl, (C1-C4)haloalkyl, (C2-C4)haloalkenyl, (C1-C4)alkylcarbamoyl-(C1-C4)alkyl, (C2- C4)alkenylcarbamoyl-(C1-C4)alkyl, (C1-C4)alkoxy-(C1-C4)alkyl, dioxolanyl-(C1-C4)alkyl, thiazolyl, furyl, furylalkyl, thienyl, piperidyl, substituted or unsubstituted phenyl, or Ce 2 ru Rnd RC 3 together form a substituted or unsubstituted tetracyclic ring, preferably an oxazolidine, thiazolidine, piperidine, morpholine, hexahydropyrimidine or benzoxazine ring; preferably: active ingredients of the dichloroacetamide type, which are frequently used as pre-emergence safeners BCS231018 Foreign countries - 23- (soil-effective safeners) can be used, such as "D z.ic Bhlormid" (N,N-Diallyl-2,2-dichloroacetamide) (S3-1), "R-29148" (3-Dichloroacetyl-2,2,5-trimethyl,13-oxazolidine) from Stauffer (S3-2), "R-287" (3-Dichloroacetyl-2,2,-dimethyl-1,3-oxazolidine) from Stauffer (S3-3), "Benoxacor" (4-Dichloroacetyl-3,4-dihydro-3-methyl-2H-1,4-benzoxazine) (S3-4), "P-P1292" (N-Allyl-N-[(1,3-dioxolan-2-yl)-methyl]-dichloroacetamide) from PPG Industries (S3-D5)K,A "-24" (N-allyl-N-[(allylaminocarbonyl)methyl]-dichloroacetamide) from Sagro-Chem (S3-6), "A7D"- or "MON 4660" (3-dichloroacetyl-1-oxa-3-aza-spiro[4,5]decane) from Nitrokemia orMaonntso (S3-7), "TI-35" (1-Dichloroacetyl-azepane) from TRI-Chemical RT (S3-8), "Diclonon" (Dicyclon)o or "BAS145138" or "LAB145138" (S3-9) ((RS)-1-Dichloroacetyl-3,3,8a-trimethylperhydropyrrol[o1,2-a]pyrimidin-6-one) from BASF, "Furilazol" or "MON 13900" ((RS)-3-Dichloroacetyl-(2-furyl)-2,2-dimethyloxazolidine) (S3-10); and its (R)-isomer (S3-11). S4) N-Acylsulfonamides of the formula (S4) and their salts R. 3 D (RD 4 )mD where the symbols and indices have the following meaning: XD is CH or N; RD 1 is CO-NRD 5 RD 6 or NHCO-RD 7 ; RD 2 is halogen, (C1-C4)-haloalkyl, (C1-C4)-haloalkoxy, nitro, (C1-C4)-alkyl, (C1-C4)-alkoxy, (C1-C4)-alkylsulfonyl, (C1-C4)-alkoxycarbonyl or (C1-C4)-alkylcarbonyl; RD 3 is hydrogen, (C1-C4)alkyl, (C2-C4)alkenyl or (C2-C4)alkynyl; RD 4is halogen, nitro, (C1-C4)-alkyl, (C1-C4)-haloalkyl, (C1-C4)-haloalkoxy, (C3-C6)-cycloalkyl, phenyl, (C1-C4)-alkoxy, cyano, (C1-C4)-alkylthio, (C1-C4)-alkylsulfinyl, (C1-C4)alkylsulfonyl, (C1-C4)alkoxycarbonyl or (C1-C4)alkylcarbonyl; R D 5 is hydrogen, (C1-C6)-alkyl, (C3-C6)-cycloalkyl, (C2-C6)-alkenyl, (C2-C6)-alkynyl, (C5-C6)-cycloalkenyl, phenyl or 3- to 6-membered Hoecteyrclyl containing D v Heteroatoms from the group nitrogen, oxygen and sulfur, where the latter radicals are substituted by substituents from the group halogen, (C-C6)alkoxy, (C1-C6)haloalkoxy, (C1-C2)alkylsulfinyl, (C1-C2)alkylsulfonyl, (C3-C6)cycloalkyl, (C1-C4)alkoxycarbonyl, (C1-C4)alkylcarbonyl and phenyl and in the case of cyclic radicals also (C1-C4)alkyl and (C1-C4)haloalkyl; BCS231018 Foreign countries - 24 - RD 6is hydrogen, (C1-C6)alkyl, (C2-C6)alkenyl or (C2-C6)alkynyl, where the last three radicals are substituted by D v radicals from the group halogen, hydroxy1,-C (C4)alkyl, (C1-C4)alkoxy and (C1-C4)alkylthio, or RD 5 and RD 6 together with the nitrogen-bearing pyrrolidinyl or piperidinyl radical; RD 7 is hydrogen, (1C-C4)alkylamino, di-(C1-C4)alkylamino, (C1-C6)alkyl, (C3-C6)cycloalkyl, where the last two radicals are substituted by substituents from the group consisting of halogen, (C1-C6)alkoxy, (C1-C6)haloalkoxy and (C1-C4)alkylthio and, in the case of cyclic radicals, also 1-(C4)alkyl and (C1-C4)haloalkyl; n D is 0, 1 or 2; m D is 1 or 2; v D is 0, 1, 2 or 3; of these, preference is given to compounds of the N-lAsuccinamide type, e.g. of the following formula (S4 a ), which are known, for example, from WO-A-97 / 45016 OOO (R 4 D ) mD where RD 7(C1-C6)alkyl, (C3-C6)cycloalkyl, where the last two radicals are substituted by substituents from the group consisting of halogen, (C1-C4)alkoxy, (C1-C6)haloalkoxy and (C1-C4)alkylthio and, in the case of cyclic radicals, also (C1-C4)alkyl and (C1-C4)haloalkyl; RD 4 Halogen, (C1-C4)alkyl, (C1-C4)alkoxy, CF3; mD is 1 or 2; vD is 0, 1, 2 or 3; and acylsulfamoylbenzoic acid amides, e.g. of the formula (S b )4, which are known for example from WO-A-99 / 16744, R 5 D BCS231018 Abroad - 25 - e.g. those in which RD 5 = Cyclopropyl and (RD 4 ) = 2-OMe is ("Cyprosulfamide", S4-1), RD 5 = Cyclopropyl and (RD 4 ) = 5-Cl-2-OMe is (S4-2), RD 5 = Ethyl and (RD 4 ) = 2-OMe is (S4-3), RD 5 = Isopropyl and (RD 4 ) = 5-Cl-2-OMe is (S4-4) and RD 5 = Isopropyl and (RD 4) = 2-OMe (S4-5). as well as compounds of the N-acylsulfamoylphenyl group of the formula (S c )4, which are known for example from EP-A-365484, 8 R D O O O 4 where R D 8 and R D 9 independently of one another hydrogen, 1-C (C8)alkyl, (C3-C8)cycloalkyl, (C3-C6)alkenyl, (C3-C6)alkynyl, R D 4 Halogen, (C1-C4)alkyl, (C1-C4)alkoxy, CF3m D1 or 2; for example 1-[4-(N-2-methoxybenzoylsulfamoyl)phenyl]-3-methylurea, 1-[4-(N-2-methoxybenzoylsulfamoyl)phenyl]-3,3-dimethylurea, 1-[4-(N-4,5-dimethylbenzoylsulfamoyl)phenyl]-3-methylurea.S5) Active ingredients from the class of hydroxyaromatic and aromatic-aliphatic carboxylic acid derivatives (S5), e.g. 3,4,5-triacetoxybenzoic acid ethyl ester, 3,5-dimethoxy-4-hydroxybenzoic acid, 3,5-dihydroxybenzoic acid, 4-hydroxysalicylic acid, 4-fluorosalicyclic acid, 2-hydroxycinnamic acid, 2,4-dichlorocinnamic acid, as described in WO-A-2004 / 084631, WO-A-2005 / 015994, WO-A-2005 / 016001. S6) Active ingredients from the class of 1,2-dihydroquinoxalin-2-ones (S6), e.g. 1-methyl-3-(2-thienyl)-1,2-dihydroquinoxalin-2-one, 1-methyl-3-(2-thienyl)-1,2-dihydroquinoxalin-2-thione, 1-(2-aminoethyl)-3-(2-thienyl)-1,2-dihydroquinoxalin-2-one hydrochloride, 1-(2-methylsulfonylaminoethyl)-3-(2-thienyl)-1,2-dihydroquinoxalin-2-one, as described in WO-A-BCS231018 Abroad - 26- 2005 / 112630. S7) Compounds of formula (S7) as described in WA-019-98 / 38856 AC E in which the symbols RE 1 , RE 2 are independently halo1,-C (C4)alkyl, (C1-C4)alkoxy, (C1-C4)haloalkyl, (C1-C4)alkylamino, di-(C1-C4)alkylamino, nitro; AE is COORE 3 or COSRE 4 RE 3 , RE 4 are independently hydrogen1,-C (C4)alkyl, (C2-C6)alkenyl, (C2-C4)alkynyl, cyanoalkyl, (C1-C4)haloalkyl, phenyl, nitrophenyl, benzyl, haloben,zyl pyridinylalkyl and alkylammonium, nE 1 is 0 or 1 nE 2 , nE 3 are independently 0, 1 or 2, preferably diphenylmethoxyacetic acid, diphenylmethoxyacetate ethyl ester, diphenylmethoxyacetate methyl ester (CAS Reg. No. 418598)-1 (9S-7-1). S8) Compounds of the formula (S8), as described in WA-098- / 27049 R F 2 O What X F CH or N, nF in case F X=N, an integer from 0 to 4 and in case that F X=CH, an integer from 0 to 5 , R F 1 Halogen, (C1-C4)alkyl, (C1-C4)haloalkyl, (C1-C4)alkoxy, (C1-C4)haloalkoxy, nitro, (C1-C4)alkylthio, (C1-C4)alkylsulfonyl, (C1-C4)alkoxycarbonyl, optionally substituted. Phenyl, possibly substituted phenoxy, BCS231018 Foreign countries - 27 - RF 2 Hydrogen or (1C-C4)alkyl RF 3 hydrogen, (C1-C8)alkyl, (C2-C4)alkenyl, (C2-C4)alkynyl, or aryl, where each of the abovementioned C-containing radicals is unsubstituted or substituted by one or more, preferably up to three identical or different radicals from the group consisting of halogen and alkoxy; or salts thereof, preferably compounds where XF is CH, nF is an integer from 0 to 2, RF 1 Halogen, (C1-C4)alkyl, (C1-C4)haloalkyl, (C1-C4)alkoxy, (C1-C4)haloalkoxy, R F 2hydrogen or (1C-C4)alkyl, R F 3 Hydrogen, (C1-C8)alkyl, (C2-C4)alkenyl, (C2-C4)alkynyl, or aryl, where each of the abovementioned C-containing radicals is unsubstituted or substituted by one or more, preferably up to three identical or different radicals from the group consisting of halogen and alkoxy, or salts thereof. S9) Active ingredients from the class of 3-(5-tetrazolylcarboxyl)-2-quinolones (S9), e.g. 1,2-dihydro-4-hydroxy-1-ethyl-3-(5-tetrazolylcarboxyl)n-2-quinolone (CAS Reg. No. 219479-18-2), 1,2-dihydro-4-hydroxy-1-methyl-3-(5-tetrazolylcarboxyl)-y2l-quinolone (CAS Reg. No. 95855-00-8), as described in WO-A-1999 / 000020. S10) Compounds of the formulas (S a )1 or (S10 b ) as described in WO-A-2007 / 023719 and WO-A-2007 / 062437 OO 3 where RG 1 Halogen, (C1-C4)alkyl, methoxy, nitro, cyano, C3F, OCF3 YG, ZG independently of each other O or S, BCS231018 Foreign countries - 28- nG is an integer from 0 to 4, RG 2 (C1-C16)alkyl, (C2-C6)alkenyl, (C3-C6)cycloalkyl, aryl; Benzyl, halobenzyl, RG 3hydrogen or (1C-C6)alkyl. S11) Active ingredients of the oxyimino compound type Sn1 (1), which are known as seed dressings, such as B. "Oxabetrinil" ((Z)-1,3-dioxolan-2-ylmethoxyimino(phenyl)acetonitrile) (S11-1), which is known as a seed dressing safener for millet against damage from metolachlor, "Fluxofenim" (1-(4-chlorophenyl)-2,2,2-trifluoro-1-ethanone-O-(1,3-dioxolan-2-ylmethyl)-ox)im (S11-2), which is known as a seed dressing safener for millet against damage from metolachlor, and "Cyomiel" tri or "CGA-43089" ((Z)-cyanomethoxyimino(phenyl)acetonitrile) (S11-3), which is known as a seed dressing safener for millet against damage from metolachlor. 12) Active ingredients from the class of isothiochromano (nSe12), such as methyl [(3-oxo-1H-2-benzothiopyran-4(3H)-ylidene)methoxy]acetate (CAS-R.Nerg. 205121-04-6) (S12-1) and related compounds from WO-A-1998 / 13361.S13) One or more compounds from group ): (S1 "3-Naphthalic anhydride" (1,8-Naphthalenedicarboxylic anhydride) (S13-1), known as a seed dressing safener for maize against damage from thiocarbamate herbicides, "Fenclorim" 6- (D4,ichloro-2-phenylpyrimidine) (S13-2), known as a safener for pretilachlor in sown rice, "F islurazole" (Benzyl 2-chloro-4-trifluoromethyl-1-,3-thiazole-5-carboxylate) (S13-3), known as a seed dressing safener for millet against damage from alachlor and metolachlor, "CL 304415" (CAS Reg. No. 1.5341-57-8) (4-Carboxy-3,4-dihydro-2H-1- benzopyran-4-acetic acid) (S13-4) from Amer Cicyaannamid, which is known as a safener for corn against damage from imidazolinones, "MG 191" (CAS-Rerg..N 96420-72-3) (2-Dichloromethyl-2-methyl-1,3-dioxolane) (S13-5) from Nitrokemia, which is known as a safener for corn, "MG-838" (CAS-Reg.No. 133993-74-5) (2-propenyl 1-oxa-4-azaspiro[4.5]de-4c-acnarbodithioate) (S13-6) from Nitrokemia, "Disulfoton" (O,O-diethyl S-2-ethylthioethyl phosphorothioate) (S13-7), "Dietholate" (O,O-diethyl-O-phenylphosphorothioate) (S13-8), "Mephenate" (4-chloroenyl methylcarbamate) (S13-9). S14) Active ingredients which, in addition to a herbicidal effect on weeds, also have a safener effect on crops such as rice, such as"Dimipeeprate" or "MY-93" (1-methyl-1-phenylethyl-piperidine-1-carbothioate), known as a safener for rice against damage from the herbicide Molinate, "Daimuron" or "SK 23" (1-(1-methyl-1-phenyleth-yl)-p-tolylurea), known as a safener for rice against damage from the herbicide Imazosulfuron, "Cumyluron" = "JC-940" (3-(2-chlorophenylmethyl)-1-(1-methyl-1-phenylethyl)-hatron, see JP-A-60087254), known as a safener for rice against damage from some herbicides, "oxyphenone" or "NK 049" (3,3'-dimethyl-4-methoxy-benzophenone), known as a safener for rice "CSB" (1-bromo-4-(chloromethylsulfonyl)benzene) from Kumiai (CSA Reg. No. 54091-06-4), which is known as a safener against damage from some herbicides in rice. BCS231018 Abroad -. 29 - S15) Compounds of formula (S15) or their derivatives as described in WO-A-2008 / 131861 and WO-A-2008 / 163018 O wherein RH 1a (C1-C6)haloalkyl radical and RH 2 hydrogen or halogen and RH 3 , RH 4independently of one another are hydrogen, C(C16)alkyl, (C2-C16)alkenyl or (C2-C16)alkynyl, where each of the last-mentioned three radicals is unsubstituted or substituted by one or more radicals from the group consisting of halogen, hydroxy, cyano, (C1-C4)alkoxy, (C1-C4)haloalkoxy, (C1-C4)alkylthio, (C1-C4)alkylamino, di[(C1-C4)alkyl]amino, [(C1-C4)alkoxy]carbonyl, [(C1-C4)haloalkoxy]carbonyl, (C3-C6)cycloalkyl, which is unsubstituted or substituted, phenyl, and hectyl, which is unsubstituted or substituted. iist, or (C3-C6)cycloalkyl, (C4-C6)cycloalkenyl, (C3-C6)cycloalkyl which is condensed on one side of the ring with a 4 to 6-membered saturated or unsaturated carbocyclic ring, or (C3-C6)cycloalkenyl which is condensed on one side of the ring with a 4 to 6-membered saturated or unsaturated carbocyclic ring,where each of the last-mentioned 4 radicals is unsubstituted or substituted by one or more radicals from the group consisting of halogen, hydroxy, cyano, (C1-C4)alkyl, (C1-C4)haloalkyl, (C1-C4)alkoxy, (C1-C4)haloalkoxy, (C1-C4)alkylthio, (C1-C4)alkylamino, di[(C1-C4)alkyl]amino, [(C1-C4)alkoxy]carbonyl, [(C1-C4)haloalkoxy]carbonyl, (C3-C6)cycloalkyl, which is unsubstituted or substituted, phenyl, which is unsubstituted or substituted, and heteroalkyl, which is unsubstituted or substituted, or R, H 3 (C1-C4)-alkoxy, (C2-C4)alkenyloxy, (C2-C6)alkynyloxy or (C2-C4)haloalkoxy and R H 4denotes hydrogen or (C1-C4)-alkyl or RH3 and RH4 together with the directly bonded N-atom form an eight-membered heterocyclic ring which, in addition to the N-atom, may also contain two hetero ring atoms, preferably up to two further hetero ring atoms from the group N, O and nth Sa, and which is unsubstituted or substituted by one or more radicals from the group consisting of halogen, C, nitro, (C1-C4)alkyl, (C1-C4)haloalkyl, (C1-C4)alkoxy, (C1-C4)haloalkoxy and (C1-C4)alkylthio. BCS231018 Foreign Countries - 30- S16) Active ingredients that are primarily used as herbicides, but also have safener effects on crops, e.g. (2,4-dichlorophenoxy)acetic acid (2,4-D), (4-chlorophenoxy)acetic acid, (R,S)-2-(4-chloro-o-tolyloxy)propionic acid (Mecopr,op 4)-(2,4-dichlorophenoxy)butyric acid (2,4-DB), (4-chloro-o-tolyloxy)acetic acid (MCPA), 4-(4-chloro-ol-yloxy)butyric acid, 4-(4-chlorophenoxy)butyric acid, 3,6-dichloro-2-methoxybenzoic acid (mDbicaa), 1-(ethoxycarbonyl)ethyl 3,6-dichloro-2-methoxybenzoate (Lactidichloro-ethyl). Particularly preferred safeners are Mefenpyr-diet Chy pl,rosulfamid, isoxadifen-ethyl, cloquintocet-mexyl, benoxacor, dichlormid and metcamifen. The following examples illustrate the invention. A. Chemical Examples Synthesis of methyl 2-chloro-4-(difluoromethoxy)-3r-methylbenzoate (2): Step 1: Preparation of methyl 2-chloro-4-(difluoromethoxy)-3-methylbenzoate (10): To a solution of 19.93 g of potassium hydroxide in 75 A mcletonitrile and 75 ml of water were added o10 g (47.35 mmol) of commercially available methyl 2l-ocrh-4-hydroxy-3-methylbenzoate (9) were added in portions. Then, 17.52 ml (94.71 mmol) of di-e[bthryom(difluoro)methyl]phosphonate were added, and the mixture was stirred for 1 h at o C 0. After addition of ethyl acetate, the organic phase was separated, dried, and evaporated. The residue was purified by chromatography (HPLC, normal phase, heptane / ethyl acetate 1→0.8 / 50 / 15). This gave 9.80 g (82%) of methyl 2-chloro-4-(difluoromethoxy)-3-methylbenzoate (10). 1 H-NMR (400 MHz, DMSO-d6): δ = 7.71 (d, 1H); 7.33 (t, 1H); 7.27 (d, 1H); 3.8s (s, 3H); 2.31 (s, 3H). Step 2: Preparation of methyl 3-(bromomethyl)c-2h-chloro-4-(difluoromethoxy)benzoate (11): 20.65 g (82.39 mmol) of methyl 2-chloro-4-(difluoromethoxy)x-3y-methylbenzoate (10) was dissolved in 200 ml of chlorobenzene and treated with 29.33 g (164.79 mmol) of r-No-msuccinimide and 1.35 g (8.24 mmol) of AIBN. The reaction mixture was stirred for 8 h at oC 12 g. It was then evaporated, and the residue was taken up in water and extracted with dimethyl ether. The organic phase was separated, dried, and evaporated. The residue was purified by chromatography (HPLC, normal phase, heptane / ethyl acetate 1→006 / 00 / 40). This gave 26.47 g (97%) of methyl 3-(bromomethyl)-2-chloro-4-(difluoromethoxy)benzoate (11). 1 H-NMR (400 MHz, DMSO-d6): δ = 7.89 (d, 1H); 7.48 (t, 1H); 7.36 (d, 1H); 4.7s (H); 3.88 (s, 3H). Step 3: Preparation of methyl 2-chloro-4-(diflurmoethoxy)-3-formylbenzoate (2): 5.96 g (18 mmol) of methyl 3-(bromomethyl)-2-chloro-4i-f(ludormethoxy)benzoate (11) were dissolved in 200 ml of acetonitrile and stirred at 1 o C0 was added portionwise with 6.36 g (54 mmol) of N-methylmorpholino-N-oxide. After the exothermic reaction had subsided, the reaction mixture was stirred at room temperature for 12 h. The mixture was then evaporated, and the residue was dissolved in water. BCS231018 Ausland - 31- and washed several times with ethyl acetate. The organic phases were combined, dried, and evaporated. The residue was purified by chromatography (HPLC, normal phase, heptane / ethyl acetate 1→006 / 00 / 40). This gave 4.33 g (90%) of methyl 2-chloro-4-(difluoromethoxy)-3-formylbenzoate (1 1 )H.-NMR (400 MHz, DMSO-d6): δ = 10.34 (s, 1H); 8.06 (d, 1H); 7.44 (d, 1H); 7.39 (t, 1H); 3.89 (s, 3H). Examples of the preparation of the compounds (II) and (I) according to the invention: Preparation of 2-chloro-3-(cyclopropylcarbonyl)-N1-m(ethyl-1H-tetrazol-5-yl)-4-(trifluoromethoxy)benzamide (1-25): Step 1: Preparation of R (,S)-methyl 2-chloro-3-[cyclopropyl(hydroxy)methyl]-4-(trifluoromethoxy)benzoate: 1.00 g (3.53 mmol) of methyl 2-chloro-3-formyl-4-(trifluoromethoxy)benzoate (1) was placed in 30 ml of dry tetrahydrofuran under argon protective gas. The mixture was stirred at -6 o0C slowly added 8.49 ml (4.24 mmol) of a 0.5M solution of cyclopropylmagnesium bromine ditetrahydrofuran and the reaction mixture was stirred for 1h at - o 6C0 and then stirred for 1 h at room temperature. The mixture was then poured onto 2M hydrochloric acid and extracted with methyl ether. The organic phase was separated, dried, and evaporated. The residue was purified by chromatography (HPLC, normal phase, heptane / ethyl acetate 1→0.6 / 0.0 / 4). This gave 1.01 g (84% R) of (S)-methyl 2-chloro-3-[cyclopropyl(hydroxy)methyl]-4-(trifluoromethoxy)benzoate. 1H-NMR (400 MHz, DMSO-d6): δ = 7.74 (d, 1H); 7.46 (br d, 1H); 5.58 (d, 1H); 74 (4m, 1H); 3.87 (s, 3H); 1.48 (m, 1H); 0.60 (m, 1H); 0.48 (m, 1H); 0 (3m, 1H); 0.18 (m, 1H). Step 2: Preparation of methyl 2-chloro-3-(cyclopropylcarbonyl)-4-(trifluoromethoxy)benzoate (3-25): 1.01 g (3.11 mmol) of R(,S)-methyl 2-chloro-3-[cyclopropyl(hydroxy)methyl]-4(t-trifluoromethoxy)benzoate was placed in 50 ml of acetone and oA 2.5M solution of chromium(VI) oxide (1.5 m3, 17.3 mmol) in a 3:1 mixture of water and sulfuric acid was slowly added dropwise to 0.15 ml of 0.0 ... Step 3: Preparation of 2-chloro-3-(cyclopropylbenzyl)-4-(trifluoromethoxy)benzoic acid (4-25): 946 mg (2.93 mmol) of methyl 2-chloro-3-(cyclopropylbenzyl)-4-(trifluoromethoxy)benzoate (3-25) were placed in 50 ml of methanol and 2.2 ml (4.39 mmol) of 2M sodium hydroxide solution were added at room temperature.The reaction mixture was stirred at room temperature for 12 h and then evaporated. The residue was taken up with water, and the aqueous solution was adjusted to pH 1 with 2M hydrochloric acid. The BCS231018 abroad -. 32The organic phase was separated, dried, and evaporated. This gave 805 mg (85%) of 2-chloro-3-(cyclopropylcarbonyl)-4-(trifluoromethoxy)benzoic acid (4-25). Step 4: Preparation of 2-chloro-3-(cyclopropylcarbonyl)-N-(1-methyl-1H-tetrazol-5-yl)-4-(trifluoromethoxy)benzamide (1-25): 200 mg (0.64 mmol) of 2-chloro-3-(cyclopropylcarbonyl)-4-(trifluoromethoxy)benzoic acid (4-25) and 98.3 mg (0 mmol) of 5-amino-1-methyl-1H-tetrazole were initially charged in 3 ml of pyridine, and 0.09 ml (0.97 mmol) of oxalyl chloride was added dropwise at room temperature. The reaction solution was stirred for 12 hours at room temperature. After adding 10 ml of water, the mixture was stirred for a further 10 minutes and then extracted with dimethyl ether. The organic phase was separated, dried, and evaporated. The residue was purified by chromatography (HPLC, C18, gradient: acetonitrile / water (+0.05% trifluoroethylene) 10 / 90→100 / 0).156 mg (59%) of 2-chloro-3-(cyclopropylcarbonyl)-N-(1-methyl-1H-tetrahydro-5-yl)-4-(trifluoromethoxy)benzamide (1-25) were obtained. The examples listed in the following tables were prepared analogously to the methods mentioned above or are available analogously to the methods mentioned above. These compounds are particularly preferred. The abbreviations used mean: Me = Methyl Et = Ethyl Pr = Propyl Bu = Butyl -Pr = iso-Propyl c-Pr = cyclo-Propyl i-Bu = iso-Butyl s-Bu = sec-Butyl Table 1: Compounds of the formula (rIm),e wlorin R. according to the invention. x represents a methyl group and the other substituents have the meanings given below. No. XYZ 1-1 Me OCF3Me 1-2 Me OCF3 Et 1 -3 Me OCF3 Pr 1-4 Me OCF3 i-Pr 1-5 Me OCF 3 c-Pr 1-6 Me OCF3 MeOCH2 1-7 Me OCF 3 ClCH2 1-8 Me OCF3 c-Pr-CH2 1-9 Me OCF3 (1-Me)c-Pr1-10 Me OCF3 CHF2 BCS231018 Ausland - 33 - Nr. X Y Z 1-11 Et OCF3 Me 1-12 Et OCF 3 Et 1-13 Et OCF3 Pr 1-14 Et OCF 3 i-Pr 1-15 Et OCF3 c-Pr 1-16 Et OCF3 MeOCH2 1-17 Et OCF3 ClCH2 1-18 Et OCF3 c-Pr-CH2 1-19 Et OCF3 (1-Me)c-Pr 1-20 Et OCF 3 CHF2 1-21 Cl OCF3 Me 1-22 Cl OCF3 Et 1-23 Cl OCF3 Pr 1-24 Cl OCF 3 i-Pr 1-25 Cl OCF3 c-Pr 1-26 Cl OCF3 MeOCH2 1-27 Cl OCF3 ClCH2 1-28 Cl OCF3 c-Pr-CH2 1-29 Cl OCF3 (1-Me)c-Pr 1-30 Cl OCF 3 CHF2 1-31 Br OCF3 Me 1-32 Br OCF 3 Et 1-33 Br OCF3 Pr 1-34 Br OCF 3 i-Pr1-35 Br OCF3 c-Pr 1-36 Br OCF3 MeOCH2 1-37 Br OCF3 ClCH2 1-38 Br OCF3 c-Pr-CH2 1-39 Br OCF3 (1-Me)c-Pr 1-40 Br OCF 3 CHF2 1-41MeOCHF2Me 1-42 Me OCHF2 Et 1-43 Me OCHF2 Pr 1-44 Me OCHF 2 i-Pr 1-45 Me OCHF2 c-Pr 1-46 Me OCHF 2 MeOCH2 1-47 Me OCHF2 ClCH2 1-48 Me OCHF2 c-Pr-CH2 1-49 Me OCHF2 (1-Me)c-Pr 1-50 Me OCHF 2 CHF2 BCS231018 Australia - 34 -Nr.XYZ 1-51 Et OCHF2 Me 1-52 Et OCHF 2 Et 1-53 Et OCHF2 Pr 1-54 Et OCHF 2 i-Pr 1-55 Et OCHF2 c-Pr 1-56 Et OCHF 2 MeOCH2 1-57 Et OCHF2 ClCH2 1-58 Et OCHF2 c-Pr-CH2 1-59 Et OCHF2 (1-Me)c-Pr1-60 Et OCHF 2 CHF2 1-61 Cl OCHF2 Me 1-62 Cl OCHF 2 Et 1-63 Cl OCHF2 Pr 1-64 Cl OCHF 2 i-Pr 1-65 Cl OCHF2 c-Pr 1-66 Cl OCHF 2 MeOCH2 1-67 Cl OCHF2 ClCH2 1-68 Cl OCHF2 c-Pr-CH2 1-69 Cl OCHF2 (1-Me)c-Pr 1-70 Cl OCHF 2 CHF2 1-71 Br OCHF2 Me 1-72 Br OCHF 2 Et 1-73 Br OCHF2 Pr 1-74 Br OCHF 2 i-Pr 1-75 Br OCHF2 c-Pr 1-76 Br OCHF 2 MeOCH2 1-77 Br OCHF2 ClCH2 1-78 Br OCHF2 c-Pr-CH2 1-79 Br OCHF2 (1-Me)c-Pr 1-80 Br OCHF 2 CHF2 1-81 Me OCF3 Bu 1-82 Me OCF 3 i-Bu 1-83 Me OCF3 s-Bu 1-84 Me OCF3 Vinyl 1-85 Me OCF3Allyl 1-86 Me OCF3 Ethinyl 1-87 Me OCF3 Prop-1-in-1-yl 1-88 Cl OCF 3 Bu 1-89 Cl OCF3 i-Bu 1-90 Cl OCF 3 s-Bu BCS231018 Ausland - 35 - Nr. X Y Z 1 -91 Cl OCF3 Vinyl 1-92 Cl OCF3 Allyl 1-93 Cl OCF3 Ethinyl 1-94 Cl OCF3 Prop-1-in-1-yl 1-95 Me OCHF2 Bu 1-96 Me OCHF 2 i-Bu 1-97 Me OCHF2 s-Bu 1-98 Me OCHF 2 Vinyl 1-99 Me OCHF2 Allyl 1-100 Me OCHF2 Ethinyl 1-101 Me OCHF2 Prop-1-in-1-yl 1-102 Cl OCHF 2 Bu 1-103 Cl OCHF2 i-Bu 1-104 Cl OCHF 2 s-Bu 1-105 Cl OCHF2 Vinyl 1-106 Cl OCHF 2 Allyl 1-107 Cl OCHF2 Ethinyl 1-108 Cl OCHF2Prop-1-yn-1-yl1-109 c-Pr OC3F Me 1-110 c-Pr OC3F Et 1-111 c-Pr OC3F c-Pr 1-112 c-Pr OCH2F Me 1-113 c-Pr OCH2F Et 1-114 c-Pr OCH2F c-Pr 1-115 Cl OCH2CHF2 Me 1-116 Cl OCH2CHF2Et 1-117 Cl OCH2CHF2 c-Pr Table 2: Compounds of the formula (rIm),e wl orin R according to the invention x represents an ethyl group and the other substituents have the meanings given below. No. XYZ 2-1 Me OCF3Me 2-2 Me OCF3 Et 2 -3 Me OCF3 Pr BCS231018 Abroad - 36 - No. XYZ 2-4 Me OCF3 i-Pr 2-5 Me OCF 3 c-Pr 2-6 Me OCF3 MeOCH2 2-7 Me OCF 3 ClCH2 2-8 Me OCF3 c-Pr-CH2 2-9 Me OCF3 (1-Me)c-Pr 2-10 Me OCF3 CHF2 2-11 Et OCF3 Me 2-12 Et OCF3 Et 2-13 Et OCF 3 Pr 2-14 Et OCF3 i-Pr 2-15 Et OCF 3 c-Pr 2-16Et OCF3 MeOCH2 2-17 Et OCF 3 ClCH2 2-18 Et OCF3 c-Pr-CH2 2-19 Et OCF3 (1-Me)c-Pr 2-20 Et OCF3 CHF2 2-21 Cl OCF3Me 2-22 Cl OCF3 Et 2-23 Cl OCF 3 Pr 2-24 Cl OCF3 i-Pr 2-25 Cl OCF 3 c-Pr 2-26 Cl OCF3 MeOCH2 2-27 Cl OCF 3 ClCH2 2-28 Cl OCF3 c-Pr-CH2 2-29 Cl OCF3 (1-Me)c-Pr 2-30 Cl OCF3 CHF2 2-31 Br OCF3 Me 2-32 Br OCF3 Et 2-33 Br OCF 3 Pr 2-34 Br OCF3 i-Pr 2-35 Br OCF 3 c-Pr 2-36 Br OCF3 MeOCH2 2-37 Br OCF 3 ClCH2 2-38 Br OCF3 c-Pr-CH2 2-39 Br OCF3 (1-Me)c-Pr 2-40 Br OCF3 CHF2 2-41 Me OCHF2Me 2-42 Me OCHF2 Et 2-43 MeOCHF2 Pr BCS231018 Australia - 37 -Nr.XYZ 2-44 Me OCHF2 i-Pr 2-45 Me OCHF 2 c-Pr 2-46 Me OCHF2 MeOCH2 2-47 Me OCHF 2 ClCH2 2-48 Me OCHF2 c-Pr-CH2 2-49 Me OCHF2 (1-Me)c-Pr 2-50 Me OCHF2 CHF2 2-51 Et OCHF2 Me 2-52 Et OCHF2 Et 2-53 Et OCHF 2 Pr 2-54 Et OCHF2 i-Pr 2-55 Et OCHF 2 c-Pr 2-56 Et OCHF2 MeOCH2 2-57 Et OCHF 2 ClCH2 2-58 Et OCHF2 c-Pr-CH2 2-59 Et OCHF2 (1-Me)c-Pr 2-60 Et OCHF2 CHF2 2-61 Cl OCHF2 Me 2-62 Cl OCHF2 Et 2-63 Cl OCHF 2 Pr 2-64 Cl OCHF2 i-Pr 2-65 Cl OCHF 2 c-Pr 2-66 Cl OCHF2 MeOCH2 2-67 Cl OCHF 2ClCH2 2-68 Cl OCHF2 c-Pr-CH2 2-69 Cl OCHF2 (1-Me)c-Pr 2-70 Cl OCHF2 CHF2 2-71 Br OCHF2 Me 2-72 Br OCHF2 Et 2-73 Br OCHF 2 Pr 2-74 Br OCHF2 i-Pr 2-75 Br OCHF 2 c-Pr 2-76 Br OCHF2 MeOCH2 2-77 Br OCHF 2 ClCH2 2-78 Br OCHF2 c-Pr-CH2 2-79 Br OCHF2 (1-Me)c-Pr 2-80 Br OCHF2 CHF2 2-81 Me OCF 3 Bu 2-82 Me OCF3 i-Bu 2-83 Me OCF 3 s-Bu BCS231018 Ausland - 38 - Nr. X Y Z 2 -84 Me OCF3 Vinyl 2-85 Me OCF3 Allyl 2-86 Me OCF3 Ethinyl 2-87 Me OCF3 Prop-1-in-1-yl 2-88 Cl OCF3 Bu 2-89 Cl OCF 3 i-Bu 2-90 Cl OCF3 s-Bu 2-91 Cl OCF3 Vinyl2-92 Cl OCF3 Allyl 2-93 Cl OCF3 Ethinyl 2-94 Cl OCF3 Prop-1-in-1-yl 2-95 Me OCHF 2 Bu 2-96 Me OCHF2 i-Bu 2-97 Me OCHF 2 s-Bu 2-98 Me OCHF2 Vinyl 2-99 Me OCHF 2 Allyl 2-100 Me OCHF2 Ethinyl 2-101 Me OCHF2 Prop-1-in-1-yl 2-102 Cl OCHF2 Bu 2-103 Cl OCHF 2 i-Bu 2-104 Cl OCHF2 s-Bu 2-105 Cl OCHF 2 Vinyl 2-106 Cl OCHF2 Allyl 2-107 Cl OCHF2 Ethinyl 2-108 Cl OCHF2Prop-1-yn-1-yl2-109 c-Pr OC3F Me 2-110 c-Pr OC3F Et 2-111 c-Pr OC3F c-Pr 2-112 c-Pr OCH2F Me 2-113 c-Pr OCH2F Et 2-114 c-Pr OCH2F c-Pr 2-115 Cl OCH2CHF2Me 2-116 Cl OCH2CHF2 Et 2-117 Cl OCH2CHF2c-Pr Table 3: Compounds of the formula (rImI)e,l according to the invention in which L is methoxy and the other substituents have the meanings given below, have BCS231018 Ausland - 39 - No. XYZ 3-1 Me OCF3 Me 3-2 Me OCF3Et 3-3 Me OCF3 Pr 3-4 Me OCF 3 i-Pr 3-5 Me OCF3 c-Pr 3-6 Me OCF 3 MeOCH2 3-7 Me OCF3 ClCH2 3-8 Me OCF3 c-Pr-CH2 3-9 Me OCF3 (1-Me)c-Pr 3-10 Me OCF 3 CHF2 3-11 Et OCF3 Me 3-12 Et OCF 3 Et 3-13 Et OCF3 Pr 3-14 Et OCF 3 i-Pr 3-15 Et OCF3 c-Pr 3-16 Et OCF3 MeOCH2 3-17Et OCF3 ClCH2 3-18 Et OCF3 c-Pr-CH2 3-19 Et OCF3 (1-Me)c-Pr 3-20 Et OCF 3 CHF2 3-21 ClOCF3Me 3-22 Cl OCF3 Et 3-23 Cl OCF3 Pr 3-24 Cl OCF 3 i-Pr 3-25 Cl OCF3 c-Pr 3-26 Cl OCF3 MeOCH2 3-27 Cl OCF3 ClCH2 3-28 Cl OCF3 c-Pr-CH2 3-29 Cl OCF3 (1-Me)c-Pr 3-30 Cl OCF 3 CHF2 3-31 Br OCF3 Me 3-32 Br OCF 3 Et 3-33 Br OCF3 Pr 3-34 Br OCF 3 i-Pr 3-35 Br OCF3 c-Pr 3-36 Br OCF3 MeOCH2 BCS231018 Australia - 40 -Nr.XYZ 3-37 Br OCF3 ClCH2 3-38 Br OCF3 c-Pr-CH2 3-39 Br OCF3 (1-Me)c-Pr 3-40 Br OCF 3 CHF2 3-41 MeOCHF2 Me 3-42 Me OCHF2 Et3-43 Me OCHF2 Pr 3-44 Me OCHF 2 i-Pr 3-45 Me OCHF2 c-Pr 3-46 Me OCHF 2 MeOCH2 3-47 Me OCHF2 ClCH2 3-48 Me OCHF2 c-Pr-CH2 3-49 Me OCHF2 (1-Me)c-Pr 3-50 Me OCHF 2 CHF2 3-51 Et OCHF2 Me 3-52 Et OCHF 2 Et 3-53 Et OCHF2 Pr 3-54 Et OCHF 2 i-Pr 3-55 Et OCHF2 c-Pr 3-56 Et OCHF 2 MeOCH2 3-57 Et OCHF2 ClCH2 3-58 Et OCHF2 c-Pr-CH2 3-59 Et OCHF2 (1-Me)c-Pr 3-60 Et OCHF 2 CHF2 3-61 Cl OCHF2 Me 3-62 Cl OCHF 2 Et 3-63 Cl OCHF2 Pr 3-64 Cl OCHF 2 i-Pr 3-65 Cl OCHF2 c-Pr 3-66 Cl OCHF 2 MeOCH2 3-67 Cl OCHF2 ClCH2 3-68 Cl OCHF2c-Pr-CH2 3-69 Cl OCHF2 (1-Me)c-Pr 3-70 Cl OCHF 2 CHF2 3-71 Br OCHF2 Me 3-72 Br OCHF 2 Et 3-73 Br OCHF2 Pr 3-74 Br OCHF 2 i-Pr 3-75 Br OCHF2 c-Pr 3-76 Br OCHF 2 MeOCH2 BCS231018 Ausland - 41 - Nr. X Y Z 3-77 Br OCHF2 ClCH2 3-78 Br OCHF2 c-Pr-CH2 3-79 Br OCHF2 (1-Me)c-Pr 3-80 Br OCHF 2 CHF2 3-81 Me OCF3 Bu 3-82 Me OCF 3 i-Bu 3-83 Me OCF3 s-Bu 3-84 Me OCF3 Vinyl 3-85 Me OCF3 Allyl 3-86 Me OCF3 Ethinyl 3-87 Me OCF3 Prop-1-in-1-yl 3-88 Cl OCF 3 Bu 3-89 Cl OCF3 i-Bu 3-90 Cl OCF 3 s-Bu 3-91 Cl OCF3 Vinyl 3-92 Cl OCF3 Allyl3-93 Cl OCF3 Ethinyl 3-94 Cl OCF3 Prop-1-in-1-yl 3-95 Me OCHF2 Bu 3-96 Me OCHF 2 i-Bu 3-97 Me OCHF2 s-Bu 3-98 Me OCHF 2 Vinyl 3-99 Me OCHF2 Allyl 3-100 Me OCHF2 Ethinyl 3-101 Me OCHF2 Prop-1-in-1-yl 3-102 Cl OCHF 2 Bu 3-103 Cl OCHF2 i-Bu 3-104 Cl OCHF 2 s-Bu 3-105 Cl OCHF2 Vinyl 3-106 Cl OCHF 2 Allyl 3-107 Cl OCHF2 Ethinyl 3-108 Cl OCHF2 Prop-1-in-1-yl3-109 c-Pr OC3F Me 3-110 c-Pr OC3F Et 3-111 c-Pr OC3F c-Pr 3-112 c-Pr OCH2F Me 3-113 c-Pr OCH2F Et 3-114 c-Pr OCH2F c-Pr 3-115 Cl OCH2CHF2 Me 3-116 Cl OCH2CHF2Et BCS231018 Ausland - 42- No. XYZ 3-117 Cl OCH2CHF2 c-Pr Table 4: Compounds according to the invention of the formula (rImI)e,l wherein L is hydroxy and the other substituents have the meanings given below, No. XYZ 4-1 Me OCF3Me 4-2 Me OCF3 Et 4 -3 Me OCF3 Pr 4-4 Me OCF3 i-Pr 4-5 Me OCF3 c-Pr 4-6 Me OCF3 MeOCH2 4-7 Me OCF3 ClCH2 4-8 Me OCF3 c-Pr-CH2 4-9 Me OCF3 (1-Me)c-Pr 4-10 Me OCF3 CHF2 4-11 Et OCF3 Me 4-12 Et OCF3 Et 4-13 Et OCF3 Pr 4-14 Et OCF3 i-Pr 4-15 Et OCF3 c-Pr 4-16 Et OCF3 MeOCH2 4-17 Et OCF3 ClCH2 4-18 Et OCF3 c-Pr-CH2 4-19 Et OCF3 (1-Me)c-Pr 4-20 Et OCF3 CHF2 4-21 Cl OCF3Me 4 -22 Cl OCF3 Et4-23 Cl OCF3 Pr 4-24 Cl OCF3 i-Pr 4-25 Cl OCF3 c-Pr 4-26 Cl OCF3 MeOCH2 4-27 Cl OCF3 ClCH2 4-28 Cl OCF3 c-Pr-CH2 BCS231018 Australia - 43 -Nr.XYZ 4-29 Cl OCF3 (1-Me)c-Pr 4-30 Cl OCF 3 CHF2 4-31 Br OCF3 Me 4-32 Br OCF 3 Et 4-33 Br OCF3 Pr 4-34 Br OCF 3 i-Pr 4-35 Br OCF3 c-Pr 4-36 Br OCF3 MeOCH2 4-37 Br OCF3 ClCH2 4-38 Br OCF3 c-Pr-CH2 4-39 Br OCF3 (1-Me)c-Pr 4-40 Br OCF 3 CHF2 4-41 MeOCHF2 Me 4-42 Me OCHF2 Et 4-43 Me OCHF2 Pr 4-44 Me OCHF 2 i-Pr 4-45 Me OCHF2 c-Pr 4-46 Me OCHF 2 MeOCH2 4-47 Me OCHF2 ClCH24-48 Me OCHF2 c-Pr-CH2 4-49 Me OCHF2 (1-Me)c-Pr 4-50 Me OCHF 2 CHF2 4-51 Et OCHF2 Me 4-52 Et OCHF 2 Et 4-53 Et OCHF2 Pr 4-54 Et OCHF 2 i-Pr 4-55 Et OCHF2 c-Pr 4-56 Et OCHF 2 MeOCH2 4-57 Et OCHF2 ClCH2 4-58 Et OCHF2 c-Pr-CH2 4-59 Et OCHF2 (1-Me)c-Pr 4-60 Et OCHF 2 CHF2 4-61 Cl OCHF2 Me 4-62 Cl OCHF 2 Et 4-63 Cl OCHF2 Pr 4-64 Cl OCHF 2 i-Pr 4-65 Cl OCHF2 c-Pr 4-66 Cl OCHF 2 MeOCH2 4-67 Cl OCHF2 ClCH2 4-68 Cl OCHF2 c-Pr-CH2 BCS231018 Australia - 44 -Nr.XYZ 4-69 Cl OCHF2 (1-Me)c-Pr 4-70 Cl OCHF 2 CHF2 4-71 Br OCHF2 Me 4-72Br OCHF 2 Et 4-73 Br OCHF2 Pr 4-74 Br OCHF 2 i-Pr 4-75 Br OCHF2 c-Pr 4-76 Br OCHF 2 MeOCH2 4-77 Br OCHF2 ClCH2 4-78 Br OCHF2 c-Pr-CH2 4-79 Br OCHF2 (1-Me)c-Pr 4-80 Br OCHF 2 CHF2 4-81 Me OCF3 Bu 4-82 Me OCF 3 i-Bu 4-83 Me OCF3 s-Bu 4-84 Me OCF3 Vinyl 4-85 Me OCF3 Allyl 4-86 Me OCF3 Ethinyl 4-87 Me OCF3 Prop-1-in-1-yl 4-88 Cl OCF 3 Bu 4-89 Cl OCF3 i-Bu 4-90 Cl OCF 3 s-Bu 4-91 Cl OCF3 Vinyl 4-92 Cl OCF3 Allyl 4-93 Cl OCF3 Ethinyl 4-94 Cl OCF3 Prop-1-in-1-yl 4-95 Me OCHF2 Bu 4-96 Me OCHF 2 i-Bu 4-97 Me OCHF2s-Bu 4-98 Me OCHF 2 Vinyl 4-99 Me OCHF2 Allyl 4-100 Me OCHF2 Ethinyl 4-101 Me OCHF2 Prop-1-yn-1-yl 4-102 Cl OCHF 2 Bu 4-103 Cl OCHF2 i-Bu 4-104 Cl OCHF 2 s-Bu 4-105 Cl OCHF2 Vinyl 4-106 Cl OCHF 2 Allyl 4-107 Cl OCHF2 Ethinyl 4-108 Cl OCHF2 Prop-1-in-1-yl BCS231018 Abroad - 45 - No. XYZ 4-109 c-Pr OC3F Me 4-110 c-Pr OC3F Et 4-111 c-Pr OC3F c-Pr 4-112 c-Pr OCH2F Me 4-113 c-Pr OCH2F Et 4-114 c-Pr OCH2F c-Pr 4-115 Cl OCH2CHF2 Me 4-116 Cl OCH2CHF2Et 4-117 Cl OCH2CHF2 c-Pr Table 5: Compounds of the formula (mII)e,l according to the invention where L is chlorine and the other substituents have the meanings given below No. XYZ 5-1 Me OCF3Me 5-2 Me OCF3 Et 5 -3 Me OCF3 Pr 5-4 Me OCF3 i-Pr 5-5 Me OCF 3 c-Pr5-6 Me OCF3 MeOCH2 5-7 Me OCF 3 ClCH2 5-8 Me OCF3 c-Pr-CH2 5-9 Me OCF3 (1-Me)c-Pr 5-10 Me OCF3 CHF2 5-11 Et OCF3 Me 5-12 Et OCF3 Et 5-13 Et OCF 3 Pr 5-14 Et OCF3 i-Pr 5-15 Et OCF 3 c-Pr 5-16 Et OCF3 MeOCH2 5-17 Et OCF 3 ClCH2 5-18 Et OCF3 c-Pr-CH2 5-19 Et OCF3 (1-Me)c-Pr 5-20 Et OCF3 CHF2 5-21 Cl OCF3Me BCS231018 Ausland - 46 - Nr. X Y Z 5-22 Cl OCF3 Et 5-23 Cl OCF 3 Pr 5-24 Cl OCF3 i-Pr 5-25 Cl OCF 3 c-Pr 5-26 Cl OCF3 MeOCH2 5-27 Cl OCF 3 ClCH2 5-28 Cl OCF3 c-Pr-CH2 5-29 Cl OCF3 (1-Me)c-Pr 5-30 Cl OCF3 CHF2 5-31 BrOCF3 Me 5-32 Br OCF3 Et 5-33 Br OCF 3 Pr 5-34 Br OCF3 i-Pr 5-35 Br OCF 3 c-Pr 5-36 Br OCF3 MeOCH2 5-37 Br OCF 3 ClCH2 5-38 Br OCF3 c-Pr-CH2 5-39 Br OCF3 (1-Me)c-Pr 5-40 Br OCF3 CHF2 5-41MeOCHF2Me 5-42 Me OCHF2 Et 5-43 Me OCHF2 Pr 5-44 Me OCHF2 i-Pr 5-45 Me OCHF 2 c-Pr 5-46 Me OCHF2 MeOCH2 5-47 Me OCHF 2 ClCH2 5-48 Me OCHF2 c-Pr-CH2 5-49 Me OCHF2 (1-Me)c-Pr 5-50 Me OCHF2 CHF2 5-51 Et OCHF2 Me 5-52 Et OCHF2 Et 5-53 Et OCHF 2 Pr 5-54 Et OCHF2 i-Pr 5-55 Et OCHF 2 c-Pr 5-56 Et OCHF2 MeOCH2 5-57Et OCHF 2 ClCH2 5-58 Et OCHF2 c-Pr-CH2 5-59 Et OCHF2 (1-Me)c-Pr 5-60 Et OCHF2 CHF2 5-61 Cl OCHF2 Me BCS231018 Australia - 47 -Nr.XYZ 5-62 Cl OCHF2 Et 5-63 Cl OCHF 2 Pr 5-64 Cl OCHF2 i-Pr 5-65 Cl OCHF 2 c-Pr 5-66 Cl OCHF2 MeOCH2 5-67 Cl OCHF 2 ClCH2 5-68 Cl OCHF2 c-Pr-CH2 5-69 Cl OCHF2 (1-Me)c-Pr 5-70 Cl OCHF2 CHF2 5-71 Br OCHF2 Me 5-72 Br OCHF2 Et 5-73 Br OCHF 2 Pr 5-74 Br OCHF2 i-Pr 5-75 Br OCHF 2 c-Pr 5-76 Br OCHF2 MeOCH2 5-77 Br OCHF 2 ClCH2 5-78 Br OCHF2 c-Pr-CH2 5-79 Br OCHF2 (1-Me)c-Pr 5-80 Br OCHF2 CHF2 5-81 Me OCF 3 Bu5-82 Me OCF3 i-Bu 5-83 Me OCF 3 s-Bu 5-84 Me OCF3 Vinyl 5-85 Me OCF3 Allyl 5-86 Me OCF3 Ethinyl 5-87 Me OCF3 Prop-1-in-1-yl 5-88 Cl OCF3 Bu 5-89 Cl OCF 3 i-Bu 5-90 Cl OCF3 s-Bu 5-91 Cl OCF3 Vinyl 5-92 Cl OCF3 Allyl 5-93 Cl OCF3 Ethinyl 5-94 Cl OCF3 Prop-1-in-1-yl 5-95 Me OCHF 2 Bu 5-96 Me OCHF2 i-Bu 5-97 Me OCHF 2 s-Bu 5-98 Me OCHF2 Vinyl 5-99 Me OCHF 2 Allyl 5-100 Me OCHF2 Ethinyl 5-101 Me OCHF2 Prop-1-in-1-yl BCS231018 Ausland - 48 - Nr. X Y Z 5 -102 Cl OCHF2 Bu 5-103 Cl OCHF 2 i-Bu 5-104 Cl OCHF2 s-Bu 5-105 Cl OCHF 2 Vinyl5-106 Cl OCHF2 Allyl 5-107 Cl OCHF2 Ethinyl 5-108 Cl OCHF2 Prop-1-yn-1-yl5-109 c-Pr OC3F Me 5-110 c-Pr OC3F Et 5-111 c-Pr OC3F c-Pr 5-112 c-Pr OCH2F Me 5-113 c-Pr OCH2F Et 5-114 c-Pr OCH2F c-Pr 5-115 Cl OCH2CHF2Me 5-116 Cl OCH2CHF2 Et 5-117 Cl OCH2CHF2c-Pr For numerous compounds of the formula (I) and (II) according to the invention mentioned in the tables above, the following NMR data are disclosed for further characterization: Example No. 1-1: 1 H NMR (400 MHz, DMSO-d6): δ = 11.68 (br s, 1H); 7.84 (d, 1H); 7.50 (d, 1H); 3.99 (s, 3H); 2.54 (s, 3H); 2.32 (s, 3H); Example No.1-2: 1 H NMR (400 MHz, DMSO-d6): δ = 11.68 (br s, 1H); 7.84 (d, 1H); 7.49 (br d, 1H 3.)9;9 (s, 3H); 2.82 (q, 2H); 2.28 (s, 3H); 1.11 (t, 3H); Example No.1-5: 1 H NMR (400 MHz, DMSO-d6): δ = 11.69 (br s, 1H); 7.85 (d, 1H); 7.51 (br d, 1H 3.)9;9 (s, 3H); 2.34 (s, 3H); 2.33 (m, 1H); 1.18 (m, 4H); Example no. 1-11: 1H-NMR (400 MHz, DMSO-d6): δ = 11.72 (br s, 1H); 7.86 (d, 1H); 7.51 (br d, 1H); 3.99 (s, 3H); 2.67 (q, 2H); 2.56 (s, 3H); 1.133 (Ht,); Beispiel-Nr. 1-12: 1 H-NMR (400 MHz, DMSO-d6): δ = 11.72 (br s, 1H); 7.86 (d, 1H); 7.51 (br d, 1H); 3.99 (s, 3H); 2.83 (q, 2H); 2.63 (q, 2H); 1.126 (Ht,); Beispiel-Nr. 1-21: 1 H-NMR (400 MHz, DMSO-d6): δ = 11.92 (br s, 1H), 7.99 (d, 1H); 7.71 (d, 1H); 4.00 (s, 3H); 2.59 (s, 3H); Beispiel-Nr. 1-2 1 2H:-NMR (400 MHz, DMSO-d6): δ = 11.92 (br s, 1H); 7.99 (d, 1H); 7.71 (d, 1H); BCS231018 Ausland - 49 - 4.00 (s, 3H); 2.87 (q, 2H); 1.13 (t, 3H); Beispiel-Nr. 1-23: 1 H-NMR (400 MHz, DMSO-d6): δ = 11.92 (br s, 1H); 7.98 (d, 1H); 7.70 (d, 1H)0;04. (s, 3H); 2.84 (t, 2H); 1.67 (m, 2H); 0.95 (t, 3H); Beispiel-Nr. 1-24: 1 H-NMR (400 MHz, DMSO-d6): δ = 11.91 (br s, 1H); 7.99 (d, 1H); 7.70 (d, 1H)0;04. (s, 3H); 3.06 (m, 1H); 1.16 (d, 6H); Beispiel-Nr. 1-25: 1H-NMR (400 MHz, DMSO-d6): δ = 11.93 (br s, 1H); 7.99 (d, 1H); 7.71 (d, 1H); 4.01 (s, 3H); 2.37 (m, 1H); 1.24 (m, 2H); 1.19 (m, 2H); Beispiel-Nr. 1-41: 1 H-NMR (400 MHz, DMSO-d6): δ = 11.60 (br s, 1H); 7.78 (d, 1H); 7.40 (t, 1H)3;07. (d, 1H); 3.98 (s, 3H); 2.29 (s, 3H); Beispiel-Nr. 1-42: 1 H-NMR (400 MHz, DMSO-d6): δ = 11.60 (br s, 1H); 7.78 (d, 1H); 7.39 (t, 1H)2;97. (d, 1H); 3.98 (s, 3H); 2.79 (q, 2H); 2.25 (s, 3H 1.)0;9 (t, 3H); Beispiel-Nr. 1-45: 1 H-NMR (400 MHz, DMSO-d6): δ = 11.60 (br s, 1H); 7.79 (d, 1H); 7.38 (t, 1H)3;07. (d, 1H); 3.98 (s, 3H); 2.30 (s, 3H); 2.29 (m, 1H 1.)1;3 (m, 4H); Beispiel-Nr. 1-51: 1 H-NMR (400 MHz, DMSO-d6): δ = 11.63 (br s, 1H); 7.80 (d, 1H); 7.41 (t, 1H)3;17. (d, 1H); 3.98 (s, 3H); 2.65 (q, 2H); 2.52 (s, 3H 1.)1;2 (t, 3H); Beispiel-Nr. 1-52: 1H-NMR (400 MHz, DMSO-d6): δ = 11.63 (br s, 1H); 7.80 (d, 1H); 7.40 (t, 1H)3;07. (d, 1H); 3.98 (s, 3H); 2.80 (q, 2H); 2.61 (q, 2H 1.)1;0 (t, 6H); Beispiel-Nr. 1-55: 1 H-NMR (400 MHz, DMSO-d6): δ = 11.64 (br s, 1H); 7.80 (d, 1H); 7.38 (t, 1H)3;17. (d, 1H); 3.99 (s, 3H); 2.68 (q, 2H); 2.31 (m, 1H 1.)1;3 (m, 7H); Beispiel-Nr. 1-61: 1 H-NMR (400 MHz, DMSO-d6): δ = 11.86 (br s, 1H); 7.91 (d, 1H); 7.48 (d, 1H); 7.44 (t, 1H); 3.99 (s, 3H); 2.54 (s, 3H); BeispNierl.- 1-62: 1 H-NMR (400 MHz, DMSO-d6): δ = 11.86 (br s, 1H); 7.91 (d, 1H); 7.48 (d, 1H); 7.43 (t, 1H); 3.99 (s, 3H); 2.83 (q, 2H); 1.113 (Ht,); Beispiel-Nr. 1-63: 1 H-NMR (400 MHz, DMSO-d6): δ = 11.86 (br s, 1H); 7.90 (d, 1H); 7.47 (d, 1H)4;37. (t, 1H); 3.98 (s, 3H); 2.80 (t, 2H); 1.66 (m, 2H 0).;95 (t, 3H); Beispiel-Nr. 1-64: 1 H-NMR (400 MHz, DMSO-d6): δ = 11.86 (br s, 1H); 7.91 (d, 1H); 7.47 (d, 1H)4;67. (t, 1H); 3.99 (s, 3H); 3.04 (m, 1H); 1.15 (d, 6H); Beispiel-Nr. 1-65: 1H-NMR (400 MHz, DMSO-d6): δ = 11.86 (br s, 1H); 7.91 (d, 1H); 7.48 (d, 1H); BCS231018 Ausland - 50 - 7.43 (t, 1H); 4.00 (s, 3H); 2.32 (m, 1H); 1.17 ( 4mH,); Beispiel-Nr. 1-103 1 :H-NMR (400 MHz, DMSO- d6): δ = 11.85 (br s, 1H); 7.90 (d, 1H); 7.47 (d, 1H)4;47. (t, 1H); 3.99 (s, 3H); 2.73 (d, 2H); 2.20 (m,) 1;H 0.97 (d, 6H); Beispiel-Nr.1-109 1 :H-NMR (400 MHz, DMSO-d6): δ = 11.65 (br s, 1H); 7.75 (d, 1H); 7.51 (d, 1H)0;34. (s, 3H); 2.60 (s, 3H); 2.23 (m, 1H); 0.91 (m, 2H 0.)5;2 (m, 2H); Beispiel-Nr.1-110 1 :H-NMR (400 MHz, DMSO-d6): δ = 11.64 (br s, 1H); 7.74 (d, 1H); 7.51 (d, 1H)0;24. (s, 3H); 2.90 (q, 2H); 2.20 (m, 1H); 1.14 (t, 3H 0).8;8 (m, 2H); 0.50 (m, 2H); Beispiel-Nr.1-111 1 :H-NMR (400 MHz, DMSO-d6): δ = 11.65 (br s, 1H); 7.75 (d, 1H); 7.52 (d, 1H)0;34. (s, 3H); 2.41 (m, 1H); 2.22 (m, 1H); 1.18 (m, 4H 0.)9;1 (m, 2H); 0.55 (m, 2H); Beispiel-Nr.1-112 1:H-NMR (400 MHz, DMSO-d6): δ = 11.56 (br s, 1H); 7.67 (d, 1H); 7.34 (t, 1H)3;17. (d, 1H); 4.02 (s, 3H); 2.55 (s, 3H); 2.19 (m, 1H 0.)8;8 (m, 2H); 0.49 (m, 2H); Beispiel-Nr.1-113 1 :H-NMR (400 MHz, DMSO-d6): δ = 11.57 (br s, 1H); 7.67 (d, 1H); 7.33 (t, 1H)3;17. (d, 1H); 4.02 (s, 3H); 2.87 (q, 2H); 2.16 (m, 1H 1.)1;3 (t, 3H); 0.85 (m, 2H); 0.48 (m, 2H); Beispiel-Nr.1-114 1 :H-NMR (400 MHz, DMSO-d6): δ = 11.57 (br s, 1H); 7.68 (d, 1H); 7.32 (t, 1H)3;27. (d, 1H); 4.02 (s, 3H); 2.37 (m, 1H); 2.18 (m, 1H 1.)1;5 (m, 4H); 0.88 (m, 2H); 0.52 (m, 2H); Beispiel-Nr.1-115 1 :H-NMR (400 MHz, DMSO-d6): δ = 11.72 (br s, 1H); 7.82 (d, 1H); 7.36 (d, 1H)4;16. (tt, 1H); 4.54 (td, 2H); 3.98 (s, 3H); 2.49 (s, 3;H) Beispiel-Nr.1-116 1 :H-NMR (400 MHz, DMSO-d6): δ = 11.72 (br s, 1H); 7.82 (d, 1H); 7.35 (d, 1H)3;96. (tt, 1H); 4.52 (td, 2H); 3.98 (s, 3H); 2.77 (q, 2;H 1).09 (t, 3H); Beispiel-Nr.1-117 1:H-NMR (400 MHz, DMSO-d6): δ = 11.73 (br s, 1H); 7.82 (d, 1H); 7.35 (d, 1H)3;76. (tt, 1H); 4.52 (td, 2H); 3.98 (s, 3H); 2.25 (, 1H 1).;09 (m, 4H); Beispiel-Nr. 2-1: 1 H-NMR (400 MHz, DMSO-d6): δ = 11.57 (br s, 1H); 7.83 (d, 1H); 7.50 (br d, 1H); 4.34 (q, 2H); 2.55 (s, 3H); 2.32 (s, 3H); 1.463 (Ht,); Beispiel-Nr.2-2: 1 H-NMR (400 MHz, DMSO-d6): δ = 11.57 (br s, 1H); 7.83 (d, 1H); 7.49 (br d, 1H 4.)3;4 (q, 2H); 2.82 (q, 2H); 2.28 (s, 3H); 1.46 (t, 3H); 1.11 (t, 3H); Beispiel-Nr.2-5: 1 H-NMR (400 MHz, DMSO-d6): δ = 11.58 (br s, 1H); 7.84 (d, 1H); 7.51 (br d, 1H 4.)3;4 (q, 2H); 2.34 (s, 3H); 2.33 (m, 1H); 1.47 (t, 3H 1).1;7 (m, 4H); Beispiel-Nr. 2-11: 1 H-NMR (400 MHz, DMSO-d6): δ = 11.61 (br s, 1H); 7.85 (d, 1H); 7.51 (br d, 1H); 4.34 (q, 2H); 2.67 (q, 2H); 2.56 (s, 3H); 1.473 (Ht,); 1.13 (t, 3H); Beispiel-Nr. 2-21: 1 H-NMR (400 MHz, DMSO-d6): δ = 11.82 (br s, 1H); 7.98 (d, 1H); 7.71 (d, 1H); BCS231018 Ausland - 51- 4.36 (q, 2H); 2.59 (s, 3H); 1.47 (t, 3H); Beispiel-Nr. 2-22: 1 H-NMR (400 MHz, DMSO-d6): δ = 11.82 (br s, 1H); 7.98 (d, 1H); 7.70 (d, 1H); 4.36 (q, 2H); 2.87 (q, 2H); 1.46 (t, 3H); 1.13 (t, 3H); Beispiel-Nr. 2-23: 1 H-NMR (400 MHz, DMSO-d6): δ = 11.82 (br s, 1H); 7.98 (d, 1H); 7.70 (d, 1H)3;64. (q, 2H); 2.85 (t, 2H); 1.68 (m, 2H); 1.47 (t, 3H 0).;96 (t, 3H); Beispiel-Nr. 2-25: 1 H-NMR (400 MHz, DMSO-d6): δ = 11.83 (br s, 1H); 7.99 (d, 1H); 7.71 (d, 1H); 4.36 (q, 2H); 2.38 (m, 1H); 1.47 (t, 3H); 1.23 ( 2mH,); 1.19 (m, 2H); Beispiel-Nr. 2-41: 1 H-NMR (400 MHz, DMSO-d6): δ = 11.49 (br s, 1H); 7.77 (d, 1H); 7.40 (t, 1H)3;07. (d, 1H); 4.33 (q, 2H); 2.28 (s, 3H); 1.46 (t, 3H); Beispiel-Nr. 2-42: 1 H-NMR (400 MHz, DMSO-d6): δ = 11.49 (br s, 1H); 7.77 (d, 1H); 7.39 (t, 1H)2;97. (d, 1H); 4.32 (q, 2H); 2.79 (q, 2H); 2.25 (s, 3H) 1;.46 (t, 3H); 1.09 (t, 3H); Beispiel-Nr. 2-45: 1H-NMR (400 MHz, DMSO-d6): δ = 11.50 (br s, 1H); 7.78 (d, 1H); 7.38 (t, 1H)3;17. (d, 1H); 4.33 (q, 2H); 3.32 (s, 3H); 2.30 (s, 3H 2.)2;9 (m, 1H); 1.46 (t, 3H); 1.13 (m, 4H); Beispiel-Nr. 2-51: 1 H-NMR (400 MHz, DMSO-d6): δ = 11.52 (br s, 1H); 7.78 (d, 1H); 7.41 (t, 1H)3;17. (d, 1H); 4.33 (q, 2H); 2.65 (q, 2H); 1.47 (t, 3H 1).;12 (t, 3H); Beispiel-Nr. 2-52: 1 H-NMR (400 MHz, DMSO-d6): δ = 11.52 (br s, 1H); 7.79 (d, 1H); 7.40 (t, 1H)3;07. (d, 1H); 4.33 (q, 2H); 2.80 (q, 2H); 2.61 (q, 2H 1.)4;7 (t, 3H); 1.10 (t, 6H); Beispiel-Nr. 2-55: 1 H-NMR (400 MHz, DMSO-d6): δ = 11.54 (br s, 1H); 7.79 (d, 1H); 7.38 (t, 1H)3;27. (d, 1H); 4.34 (q, 2H); 2.67 (q, 2H); 2.31 (m, 1H 1.)4;7 (t, 3H); 1.12 (m, 7H); Beispiel-Nr. 2-61: 1 H-NMR (400 MHz, DMSO-d6): δ = 11.75 (br s, 1H); 7.91 (d, 1H); 7.48 (d, 1H); 7.44 (t, 1H); 4.35 (q, 2H); 2.54 (s, 3H); 1.463 (Ht,); Beispiel-Nr. 2-62: 1H-NMR (400 MHz, DMSO-d6): δ = 11.75 (br s, 1H); 7.90 (d, 1H); 7.48 (d, 1H); 7.43 (t, 1H); 4.35 (q, 2H); 2.82 (q, 2H); 1.46 (t, 3H); 1.11 (t, 3H); Beispiel-Nr. 2-65: 1 H-NMR (400 MHz, DMSO-d6): δ = 11.76 (br s, 1H); 7.90 (d, 1H); 7.48 (d, 1H); 7.43 (t, 1H); 4.36 (q, 2H); 2.31 (m, 1H); 1.473 (Ht,); 1.17 (m, 4H); Beispiel-Nr.2-103 1 :H-NMR (400 MHz, DMSO-d6): δ = 11.75 (br d, 1H); 7.90 (d, 1H); 7.47 (d, 1H)4;47. (t, 1H); 4.35 (q, 2H); 2.73 (d, 2H); 2.20 (m, 1H 1).4;6 (t, 3H); 0.98 (d, 6H); BCS231018 Ausland - 52 - Beispiel-Nr.2-109 1 :H-NMR (400 MHz, DMSO-d6): δ = 11.53 (br s, 1H); 7.74 (d, 1H); 7.51 (d, 1H)3;74. (q, 2H); 2.60 (s, 3H); 2.23 (m, 1H); 1.48 (t, 3H 0).9;1 (m, 2H); 0.53 (m, 2H); Beispiel-Nr.2-110 1 :H-NMR (400 MHz, DMSO-d6): δ = 11.52 (br s, 1H); 7.74 (d, 1H); 7.51 (d, 1H)3;74. (q, 2H); 2.90 (q, 2H); 2.20 (m, 1H); 1.48 (t, 3H 1).1;4 (t, 3H); 0.88 (m, 2H); 0.51 (m, 2H); Beispiel-Nr.2-111 1:H-NMR (400 MHz, DMSO-d6): δ = 11.53 (br s, 1H); 7.75 (d, 1H); 7.52 (d, 1H)3;74. (q, 2H); 2.41 (m, 1H); 2.21 (m, 1H); 1.49 (t, 3H 1).;19 (m, 4H); 0.90 (m, 2H); 0.56 (m, 2H); Beispiel-Nr.2-112 1 :H-NMR (400 MHz, DMSO-d6): δ = 11.44 (br s, 1H); 7.67 (d, 1H); 7.34 (t, 1H)3;17. (d, 1H); 4.36 (q, 2H); 2.56 (s, 3H); 2.18 (m, 1H 1.)4;8 (t, 3H); 0.88 (m, 2H); 0.50 (m, 2H); Beispiel-Nr.2-113 1 :H-NMR (400 MHz, DMSO-d6): δ = 11.45 (br s, 1H); 7.66 (d, 1H); 7.33 (t, 1H)3;17. (d, 1H); 4.36 (q, 2H); 2.87 (q, 2H); 2.16 (m, 1H 1).;48 (t, 3H); 1.13 (t, 3H); 0.85 (m, 2H); 0.48 (m, 2H); Beispiel-Nr.2-114 1 :H-NMR (400 MHz, DMSO-d6): δ = 11.45 (br s, 1H); 7.67 (d, 1H); 7.32 (t, 1H)3;27. (d, 1H); 4.36 (q, 2H); 2.37 (m, 1H); 2.17 (m, 1H 1.)4;9 (t, 3H); 1.15 (m, 4H); 0.88 (m, 2H); 0.52 ( 2mH,); Beispiel-Nr.2-115 1:H-NMR (400 MHz, DMSO-d6): δ = 11.62 (br s, 1H); 7.81 (d, 1H); 7.36 (d, 1H)4;16. (tt, 1H); 4.54 (td, 2H); 4.33 (q, 2H); 2.50 (s, 3;H 1).46 (t, 3H); Beispiel-Nr.2-116 1 :H-NMR (400 MHz, DMSO-d6): δ = 11.62 (br s, 1H); 7.81 (d, 1H); 7.35 (d, 1H)3;96. (tt, 1H); 4.52 (td, 2H); 4.33 (q, 2H); 2.77 (q, 2 qH,); 1.46 (t, 3H); 1.09 (t, 3H); Beispiel-Nr.2-117 1 :H-NMR (400 MHz, DMSO-d6): δ = 11.62 (br s, 1H); 7.81 (d, 1H); 7.35 (d, 1H)3;76. (tt, 1H); 4.52 (td, 2H); 4.34 (q, 2H); 2.24 (m, 1;H 1).46 (t, 3H); 1.10 (m, 4H); Beispiel-Nr. 3-1: 1 H-NMR (400 MHz, CDC3l): δ = 7.92 (d, 1H); 7.18 (d, 1H); 3.91 (s, 3H); 2.5s2, 3 (H); 2.48 (s, 3H); Beispiel-Nr.3-2 1 H: -NMR (400 MHz, DMSO-d6): δ = 7.94 (d, 1H); 7.43 (br d, 1H); 3.86 (s, 3H); 2.79 (q, 2H); 2.34 (s, 3H); 1.09 (t, 3H); Beispiel-Nr.3-5: 1 H-NMR (400 MHz, DMSO-d6): δ = 7.96 (d, 1H); 7.45 (br d, 1H); 3.86 (s, 3H);02. (4s, 3H); 3.32 (m, 1H); 1.16 (m, 4H); Beispiel-Nr. 3-11: 1H-NMR (400 MHz, DMSO-d6): δ = 7.94 (d, 1H); 7.45 (br d, 1H); 3.86 (s, 3H);42.7 (q, 2H); 2.53 (s, 3H); 1.09 (t, 3H); Beispiel-Nr. 3-12: 1 H-NMR (400 MHz, DMSO-d6): δ = 7.94 (d, 1H); 7.44 (br d, 1H); 3.86 (s, 3H);02.8 (q, 2H); 2.70 (q, 2H); 1.10 (t, 3H); 1.08 (t, 3H); Beispiel-Nr. 3-15: 1 H-NMR (400 MHz, DMSO-d6): δ = 7.94 (d, 1H); 7.46 (br d, 1H); 3.87 (s, 3H);92.7 (q, 2H); 2.33 (m, 1H); 1.17 (m, 4H); 1.11 (t, 3H); BCS231018 Ausland - 53 - Beispiel-Nr. 3-21: 1 H-NMR (400 MHz, DMSO-d6): δ = 8.02 (d, 1H); 7.64 (d, 1H); 3.90 (s, 3H); 2,5s6, ( 3H); Beispiel-Nr.3-22: 1 H-NMR (400 MHz, CDC3l): δ = 7.90 (d, 1H); 7.28 (d, 1H); 3.95 (s, 3H); 2.8q1, 2 (H); 1.23 (t, 3H); Beispiel-Nr. 3-23: 1 H-NMR (400 MHz, DMSO-d6): δ = 8.02 (d, 1H); 7.64 (br d, 1H); 3.89 (s, 3H);22.8 (t, 2H); 1.65 (m, 2H); 0.94 (t, 3H); Beispiel-Nr. 3-24: 1H-NMR (400 MHz, DMSO-d6): δ = 8.04 (d, 1H); 7.64 (br d, 1H); 3.90 (s, 3H);43.0 (m, 1H); 1.14 (d, 6H); Beispiel-Nr. 3-25: 1 H-NMR (400 MHz, DMSO-d6): δ = 8.03 (d, 1H); 7.65 (d, 1H); 3.90 (s, 3H); 2.38 (m, 1H); 1.21 (m, 2H); 1.17 (m, 2H); BeispNierl.- 3-41: 1 H-NMR (400 MHz, DMSO-d6): δ = 7.90 (d, 1H); 7.39 (t, 1H); 7.24 (d, 1H); 3.84 (s, 3H 2.)3;5 (s, 3H); Beispiel-Nr. 3-42: 1 H-NMR (400 MHz, DMSO-d6): δ = 7.91 (d, 1H); 7.38 (t, 1H); 7.24 (d, 1H); 3.8s3, ( 3H); 2.76 (q, 2H); 2.31 (s, 3H); 1.08 (t, 3H); Beispiel-Nr. 3-45: 1 H-NMR (400 MHz, DMSO-d6): δ = 7.92 (d, 1H); 7.37 (t, 1H); 7.25 (d, 1H); 3.8s4, ( 3H); 2.37 (s, 3H); 2.28 (m, 1H); 1.11 (m, 4H); Beispiel-Nr. 3-51: 1 H-NMR (400 MHz, DMSO-d6): δ = 7.90 (d, 1H); 7.40 (t, 1H); 7.25 / d, 1H); 3.8s4, ( 3H); 2.73 (q, 2H); 1.09 (t, 3H); Beispiel-Nr. 3-52: 1H-NMR (400 MHz, DMSO-d6): δ = 7.91 (d, 1H); 7.39 (t, 1H); 7.24 (d, 1H); 3.8s4, ( 3H); 2.78 (q, 2H); 2.69 (q, 2H); 1.08 (t, 3H); 1. (0t,73H); Beispiel-Nr. 3-55: 1 H-NMR (400 MHz, DMSO-d6): δ = 7.91 (d, 1H); 7.38 (t, 1H); 7.26 (d, 1H); 3.8s5, ( 3H); 2.77 (q, 2H); 2.30 (m, 1H); 1.12 (m, 4H); 1. (0t,93H); Beispiel-Nr. 3-61: 1 H-NMR (400 MHz, DMSO-d6): δ = 7.98 (d, 1H); 7.43 (t, 1H); 7.43 (d, 1H); 3.87 (s, 3H); 2.52 (s, 3H); Beispiel-Nr. 3-6 1 2H:-NMR (400 MHz, DMSO-d6): δ = 7.98 (d, 1H); 7.42 (d, 1H); 7.42 (t, 1H); 3,87 (s, 3H); 2.80 (q, 2H); 1.10 (t, 3H); Beispiel-Nr. 3-63: 1 H-NMR (400 MHz, DMSO-d6): δ = 7.97 (d, 1H); 7.43 (d, 1H); 7.42 (t, 1H); 3.87 (s, 3H); 2.78 (t, 2H); 1.64 (m, 2H); 0.943 (Ht,); Beispiel-Nr. 3-64: 1 H-NMR (400 MHz, DMSO-d6): δ = 7.98 (d, 1H); 7.45 (t, 1H); 7.42 (d, 1H); 3.8s7, ( 3H); 3.01 (m, 1H); 1.14 (d, 6H); BCS231018 Ausland - 54 - Beispiel-Nr. 3-65: 1H-NMR (400 MHz, DMSO-d6): δ = 7.97 (d, 1H); 7.43 (d, 1H); 7.42 (t, 1H); 3.88 (s, 3H); 2.31 (m, 1H); 1.17 (m, 2H); 1.13 ( 2mH,); Beispiel-Nr.3-103 1 :H-NMR (400 MHz, DMSO- d6): δ = 7.97 (d, 1H); 7.43 (t, 1H); 7.41 (d, 1H); 3.8s7, 3 (H); 2.70 (d, 2H); 2.19 (m, 1H); 0.96 (d, 6H); Beispiel-Nr. 3-107: 1 H-NMR (400 MHz, DMSO-d6): δ = 8.07 (d, 1H); 7.50 (d, 1H); 7.49 (t, 1H); 5.41 (1H); 3.88 (s, 3H); Beispiel-Nr. 3-108: 1 H-NMR (400 MHz, DMSO-d6): δ = 8.02 (d, 1H); 7.45 (d, 1H); 7.45 (t, 1H); 3.8s8, ( 3H); 2.16 (s, 3H); Beispiel-Nr. 3-109: 1 H-NMR (400 MHz, DMSO-d6): δ = 7.72 (d, 1H); 7.45 (br d, 1H); 3.88 (s, 3H);82.5 (s, 3H); 2.16 (m, 1H); 0.89 (m, 2H); 0.39 (m, 2H); Beispiel-Nr. 3-110: 1 H-NMR (400 MHz, DMSO-d6): δ = 7.72 (d, 1H); 7.44 (br d, 1H); 3.88 (s, 3H);92.8 (q, 2H); 2.14 (m, 1H); 1.12 (t, 3H); 0.86 (m, 2H 0).;36 (m, 2H); Beispiel-Nr. 3-111: 1H-NMR (400 MHz, DMSO-d6): δ = 7.73 (d, 1H); 7.46 (br d, 1H); 3.88 (s, 3H);22.4 (m, 1H); 2.12 (m, 1H); 1.16 (m, 4H); 0.88 (m, 2H 0).4;0 (m, 2H); Beispiel-Nr. 3-112: 1 H-NMR (400 MHz, DMSO-d6): δ = 7.66 (d, 1H); 7.32 (t, 1H); 7.25 (d, 1H); 3.8s5, ( 3H); 2.53 (s, 3H); 2.10 (m, 1H); 0.86 (m, 2H); 0. (3m5, 2H); Beispiel-Nr. 3-113: 1 H-NMR (400 MHz, DMSO-d6): δ = 7.66 (d, 1H); 7.31 (t, 1H); 7.24 (d, 1H); 3.8s5, ( 3H); 2.85 (br q, 2H); 2.10 (m, 1H); 1.11 (br t, 3;H 0).83 (m, 2H); 0.33 (m, 2H); Beispiel-Nr. 3-114: 1 H-NMR (400 MHz, DMSO-d6): δ = 7.67 (d, 1H); 7.30 (t, 1H); 7.26 (d, 1H); 3.8s5, ( 3H); 2.37 (m, 1H); 2.08 (m, 1H); 1.13 (m, 4H); 0. (8m6, 2H); 0.38 (m, 2H); Beispiel-Nr. 3-115: 1 H-NMR (400 MHz, DMSO-d6): δ = 7.92 (d, 1H); 7.31 (d, 1H); 6.39 (tt, 1H); 4.52 (td, 2H); 3.84 (s, 3H); 2.46 (s, 3H); Beispiel-Nr. 3-116: 1H-NMR (400 MHz, DMSO-d6): δ = 7.92 (d, 1H); 7.30 (d, 1H); 6.37 (tt, 1H); 4.50 (td, 2H); 3.84 (s, 3H); 2.74 (q, 2H); 1.07 (t, 3H); Beispiel-Nr. 3-117: 1 H-NMR (400 MHz, DMSO-d6): δ = 7.92 (d, 1H); 7.30 (d, 1H); 6.36 (tt, 1H); 4.50 (td, 2H); 3.84 (s, 3H); 2.23 (m, 1H); 1.08 (m, 4H); Beispiel-Nr. 4-1: 1 H-NMR (400 MHz, DMSO-d6): δ = 13.34 (br s, 1H); 7.94 (d, 1H); 7.40 (d, 1H); 2.50 (s, 3H); 2.39 (s, 3H); Beispiel-Nr.4-2: 1 H-NMR (400 MHz, DMSO-d6): δ = 13.33 (br s, 1H); 7.94 (d, 1H); 7.40 (br d, 1H 2.)7;9 (q, 2H); 2.35 (s, 3H); 1.09 (t, 3H); BCS231018 Ausland - 55 - Beispiel-Nr.4-5: 1 H-NMR (400 MHz, DMSO-d6): δ = 13.34 (br s, 1H); 7.95 (d, 1H); 7.41 (br d, 1H 2.)4;2 (s, 3H); 2.32 (m, 1H); 1.15 (m, 4H); Beispiel-Nr. 4-11: 1 H-NMR (400 MHz, DMSO-d6): δ = 13.39 (br s, 1H); 7.93 (d, 1H); 7.41 (br d, 1H); 2.78 (q, 2H); 2.53 (s, 3H); 1.10 (t, 3H); Beispiel-Nr. 4-12: 1H-NMR (400 MHz, DMSO-d6): δ = 7.93 (d, 1H); 7.40 (br d, 1H); 2.80 (q, 2H);42.7 (q, 2H); 1.10 (t, 3H); 1.09 (t, 3H); Beispiel-Nr. 4-21: 1 H-NMR (400 MHz, DMSO-d6): δ = 13.86 (br s, 1H); 7.99 (d, 1H); 7.60 (d, 1H)5;62. (s, 3H); Beispiel-Nr. 4-22 1 :H-NMR (400 MHz, DMSO-d6): δ = 13.86 (br s, 1H); 7.99 (d, 1H); 7.59 (d, 1H); 2.83 (q, 2H); 1.11 (t, 3H); Beispiel-Nr.4-23: 1 H-NMR (400 MHz, DMSO-d6): δ = 13.86 (br s, 1H); 7.99 (d, 1H); 7.59 (bd, 1H.)8;12 (t, 2H); 1.65 (m, 2H); 0.94 (t, 3H); Beispiel-Nr. 4-24: 1 H-NMR (400 MHz, DMSO-d6): δ = 13.90 (br s, 1H); 8.00 (d, 1H); 7.60 (br d, 1H); 3.03 (m, 1H); 1.14 (d, 6H); Beispiel-Nr. 4-25: 1 H-NMR (400 MHz, DMSO-d6): δ = 13.85 (br s, 1H); 7.99 (d, 1H); 7.61 (d, 1H); 2.37 (m, 1H); 1.23-1.14 (m, 4H); Beispiel-Nr.4-4 1 H1:-NMR (400 MHz, DMSO-d6): δ = 13.21 (br s, 1H); 7.90 (d, 1H); 7.37 (t, 1H); 7.21 (d, 1H); 2.48 (s, 3H); 2.36 (s, 3H); Beispiel-Nr. 4-42: 1H-NMR (400 MHz, DMSO-d6): δ = 13.11 (br s, 1H); 7.90 (d, 1H); 7.36 (t, 1H); 7.20 (d, 1H); 2.76 (q, 2H); 2.33 (s, 3H); 1.083 (Ht,); Beispiel-Nr. 4-45: 1 H-NMR (400 MHz, DMSO-d6): δ = 13.11 (br s, 1H); 7.92 (d, 1H); 7.35 (t, 1H); 7.21 (d, 1H); 2.38 (s, 3H); 2.27 (m, 1H); 1.10 ( 4mH,); BCS231018 Ausland - 56 - Beispiel-Nr. 4-51: 1 H-NMR (400 MHz, DMSO-d6): δ = 13.15 (br s, 1H); 7.90 (d, 1H); 7.38 (t, 1H)2;17. (d, 1H); 2.77 (q, 2H); 2.49 (s, 3H); 1.09 (t, 3H); Beispiel-Nr. 4-52: 1 H-NMR (400 MHz, DMSO-d6): δ = 13.13 (br s, 1H); 7.91 (d, 1H); 7.37 (t, 1H)2;17. (d, 1H); 2.77 (m, 4H); 1.08 (m, 6H); Beispiel-Nr. 4-55: 1 H-NMR (400 MHz, DMSO-d6): δ = 13.14 (br s, 1H); 7.91 (d, 1H); 7.36 (t, 1H)2;27. (d, 1H); 2.81 (q, 2H); 2.29 (m, 1H); 1.11 (m, 4H 1).0;9 (t, 3H); Beispiel-Nr. 4-61: 1 H-NMR (400 MHz, DMSO-d6): δ = 13.63 (br s, 1H); 7.95 (d, 1H); 7.41 (t, 1H); 7.39 (d, 1H); 2.53 (s, 3H); Beispiel-Nr. 4-62: 1H-NMR (400 MHz, DMSO-d6): δ = 13.63 (br s, 1H); 7.95 (d, 1H); 7.40 (t, 1H); 7.38 (d, 1H); 2.79 (q, 2H); 1.09 (t, 3H); BeispNierl.- 4-63: 1 H-NMR (400 MHz, DMSO-d6): δ = 13.62 (br d, 1H); 7.95 (d, 1H); 7.40 (t, 1H); 7.38 (d, 1H.)7;72 (t, 2H); 1.64 (m, 2H); 0.94 (t, 3H); Beispiel-Nr. 4-64: 1 H-NMR (400 MHz, DMSO-d6): δ = 13.65 (br s, 1H); 7.95 (d, 1H); 7.43 (t, 1H)3;87. (d, 1H); 3.01 (m, 1H); 1.13 (d, 6H); Beispiel-Nr. 4-65: 1 H-NMR (400 MHz, DMSO-d6): δ = 13.62 (br s, 1H); 7.95 (d, 1H); 7.40 (t, 1H); 7.39 (d, 1H); 2.30 (m, 1H); 1.19-1.09 (m, 4H); Beispiel-Nr.4-103 1 :H-NMR (400 MHz, DMSO-d6): δ = 7.94 (d, 1H); 7.41 (t, 1H); 7.37 (d, 1H); 2.7d0, ( 2H); 2.19 (m, 1H); 0.96 (d, 6H); Beispiel-Nr. 4-109: 1 H-NMR (400 MHz, DMSO-d6): δ = 13.30 (br s, 1H); 7.70 (d, 1H); 7.41 (d, 1);92.5 (s, 3H); 2.16 (m, 1H); 0.89 (m, 2H); 0.43 (m, 2H); Beispiel-Nr. 4-110: 1H-NMR (400 MHz, DMSO-d6): δ = 7.67 (d, 1H); 7.39 (br d, 1H); 2.88 (q, 2H);42.1 (m, 1H); 1.12 (t, 3H); 0.85 (m, 2H); 0.41 (m, 2H); Beispiel-Nr. 4-111: 1 H-NMR (400 MHz, DMSO-d6): δ = 13.29 (br s, 1H); 7.71 (d, 1H); 7.42 (br d, 1H); 2.40 (m, 1H); 2.11 (m, 1H); 1.15 (m, 4H); 0.88 ( 2mH,); 0.46 (m, 2H); Beispiel-Nr.4-112 1 :H-NMR (400 MHz, DMSO-d6): δ = 13.12 (br s, 1H); 7.64 (d, 1H); 7.29 (t, 1H)2;17. (d, 1H); 2.49 (s, 3H); 2.11 (m, 1H); 0.86 (m, 2H 0.)4;0 (m, 2H); Beispiel-Nr.4-113 1 :H-NMR (400 MHz, DMSO-d6): δ = 13.11 (br s, 1H); 7.64 (d, 1H); 7.28 (t, 1H)2;17. (d, 1H); 2.85 (q, 2H); 2.11 (m, 1H); 1.10 (t, 3H 0).8;3 (m, 2H); 0.38 (m, 2H); BCS231018 Ausland - 57 - Beispiel-Nr.4-114 1 :H-NMR (400 MHz, DMSO-d6): δ = 13.10 (br s, 1H); 7.65 (d, 1H); 7.27 (t, 1H)2;27. (d, 1H); 2.36 (m, 1H); 2.09 (m, 1H); 1.12 (m, 4H 0).8;6 (m, 2H); 0.41 (m, 2H); Beispiel-Nr.4-115 1:H-NMR (400 MHz, DMSO-d6): δ = 13.30 (br s, 1H); 7.90 (d, 1H); 7.27 (d, 1H)3;96. (tt, 1H); 4.50 (td, 2H); 2.46 (s, 3H); Beispiel-Nr.4-116 1 :H-NMR (400 MHz, DMSO-d6): δ = 13.30 (br s, 1H); 7.90 (d, 1H); 7.27 (d, 1H)3;76. (tt, 1H); 4.49 (td, 2H); 2.74 (q, 2H); 1.07 (t, 3;H) Beispiel-Nr.4-117 1:H-NMR (400 MHz, DMSO-d6): δ = 13.29 (br s, 1H); 7.90 (d, 1H); 7.27 (d, 1H); 56 (tt, 1H); 4.48 (td, 2H); 2.22 (m, 1H); 1.07 (m, 4H) B. Formulation examples a) A dusting agent is obtained by mixing 10 parts by weight of a compound of the formula (I) and / or salts thereof and 90 parts by weight of talc and comminuting in a hammer mill. b) A wettable prepowder which is easily dispersible in water is obtained by mixing 25 parts by weight of a compound of formula (I) and / or its salts, 64 parts by weight of kaolin-containing quartz as an inert substance, 10 parts by weight of potassium ligninsulfonate and 1 part by weight of sodium oleoylmethyltaurine as wetting and desiccant agent and grinding the mixture in a pin mill. c) A dispersion concentrate which is easily dispersible in water is obtained by mixing 20 parts by weight of a compound of formula (I) and / or its salts with 6 parts by weight of alkylphenol polyglycol ether (®Triton X 207), 3 parts by weight of isotridecanol polyglycol ether (8 EO) and 71 parts by weight of-parts of paraffinic mineral oil (temperature range, for example, approx. 255 to over 277 °C) and ground in a ball mill to a fineness of less than 5 microns. d) An emulsifiable concentrate is obtained from 1 part by weight of a compound of formula (I) and / or salts thereof, 75 parts by weight of cyclohexanone solvent and 10 parts by weight of ethoxylated nonylphenol as emulsifier. e) Water-dispersible granules are obtained by mixing 75 parts by weight of a compound of formula (I) and / or salts thereof, 10 parts by weight of calcium ligninsulfonate, 5 parts by weight of sodium lauryl sulfate, 3 parts by weight of polyvinyl alcohol and BCS231018 abroad -. 58- 7 parts by weight of kaolin are mixed, ground on a pin mill, and the powder is granulated in a fluidized bed by spraying water as the granulating liquid. f) Water-dispersible granules are obtained by homogenizing and pre-comminution in a colloid mill 25 parts by weight of a compound of formula (I) and its salts, 5 parts by weight of 2,2'-dinaphthylmethane-6,6'-disulfonic acid sodium, 2 parts by weight of oleoylmethyltaurine sodium, 1 part by weight of polyvinyl alcohol, 17 parts by weight of calcium carbonate, and 50 parts by weight of water, then grinding on a bead mill, and atomizing and drying the resulting suspension in a spray device using a single-component nozzle. C.Biological examples The abbreviations used here mean: ABUTH Abutilon theophrasti ALOMY Alopecurus myuorsoides AVEFA Avena fatua AMARE Amaranthus retroflexus CYPES Cyperus esculentus DIGSA Digitaria sanagluisi ECHCG Echinochloa crus-galli HORMU Hordeum murmin KCHSC Kochia scoparia LOLMU Lolium multiflorum LOLRI Lolium rigidum MATIN Matricaria inodora PHBPU Pharbitis purpurea POLCO Polygonum covnuvlouls SETVI Setaria viridis STEME Stellaria media VERPE Veronica persica VIOTR Viola tricolor BCS231018 Foreign -. 59- 1. Herbicidal action against weeds in advance: Seeds of monocotyledonous or dicotyledonous weeds or cultivars are sown in wood fiber pots in sandy loam soil and covered with soil. The compounds according to the invention, formulated as wettable powders (WP) or emulsion concentrates (EC), are then applied to the surface of the soil as an aqueous suspension or emulsion at a water application rate of the equivalent of 600 to 800 l / ha, with the addition of 0.2% wetting agent. After treatment, the pots are placed in a greenhouse and kept under favorable growth conditions for the test plants. The visual assessment of damage to the affected plants is carried out after a trial period of 3 weeks in comparison to untreated control plants (icide effect in percent (%): 100% effect = plants are dead, 0% effect = like untreated plants).Numerous compounds according to the invention demonstrated very good activity against a wide range of important weeds. The following tables illustrate the postemergence herbicidal activity of the compounds according to the invention, with the herbicidal activity expressed as a percentage. Table C-1: Pre-emergence effect at 20g / ha against ZMEXA in % Example Dosage XM number [g / ha] AEZ 1-21 20 0 2-21 20 0 2-25 20 0 1-25 20 20 1-65 20 0 2-65 20 0 1-62 20 0 2-22 20 0 2-62 20 0 Table C-2: Pre-emergence effect at 80g / ha against ZMEXA in % Example Dosage XM number [g / ha] AEZ 2-21 80 0 Table C-3: Pre-emergence effect at 20g / ha against TARSZ in % BCS231018 Abroad -. 60 - Example dosage SA number [g / ha] ZRT 2-21 20 0 1-62 20 0 1-22 20 0 2-22 20 0 2-62 20 0 2-61 20 0 1-1 20 0 2-1 20 0 1-2 20 0 2-2 20 0 1-42 20 0 2-42 20 0 1-41 20 10 1-64 20 10 1-24 20 10 1-45 20 20 2-41 20 10 2-5 20 20 2-103 20 0 1-103 20 0 Table C-4: Pre-emergence effect at 80g / ha against TARSZ in % Example dosage S A number [g / ha] ZRT 2-22 80 10 1-42 80 0 2-42 80 0 2-103 80 0 1-103 80 10 Table C-5: Pre-emergence effect at 20g / ha against GMLAX in % Example Dosage AM number [g / ha] X L G 1-25 20 20 2-22 20 0 BCS231018 Abroad - 61- Table C-6: Pre-emergence effect at 20g / ha against ATBHU in % Example Dosage HT number [g / ha] UBA 1-21 20 100 2-21 20 100 2-25 20 90 1-25 20 90 1-61 20 100 1-65 20 100 2-65 20 100 1-62 20 100 1-22 20 100 2-22 20 100 2-62 20 100 Table C-7: Pre-emergence effect at 80g / ha against ATBHU in % Example Dosage HT number [g / ha] UBA 1-21 80 100 2-21 80 100 2-25 80 100 1-25 80 100 1-61 80 100 1-65 80 100 2-65 80 100 1-62 80 100 1-22 80 100 2-22 80 100 2-62 80 100 Table C-8: Pre-emergence effect at 20g / ha against AMLYO in % Example Dosage YM number [g / ha] O L A 1-65 20 100 1-2 20 90 1-45 20 80 1-5 20 90 2-5 20 90 BCS231018 Abroad - 62 - Table C-9: Pre-emergence effect at 80g / ha against AMLYO in % Example dosage YM number [g / ha] O LA 1-21 80 80 2-21 80 80 2-25 80 90 1-25 80 90 1-61 80 90 1-65 80 100 2-65 80 100 1-62 80 100 1-22 80 80 2-22 80 80 2-61 80 90 2-1 80 80 1-2 80 100 2-2 80 90 1-42 80 90 1-41 80 100 1-45 80 100 2-45 80 100 1-5 80 100 2-41 80 100 2-5 80 100 Table C-10: Pre-emergence effect at 20g / ha against ARME in % Example Dosage ER number [g / ha] AMA 1-21 20 100 2-21 20 100 2-25 20 100 1-25 20 90 1-61 20 100 1-65 20 100 2-65 20 100 1-62 20 100 1-22 20 100 2-22 20 100 2-62 20 100 BCS231018 Abroad - 63 - Table C-11: Pre-emergence effect at 80g / ha against ARME in % Example Dosage ER number [g / ha] AMA 1-21 80 100 2-21 80 100 2-25 80 100 1-25 80 100 1-61 80 100 1-65 80 100 2-65 80 100 1-62 80 100 1-22 80 100 2-22 80 100 2-62 80 100 Table C-12: Pre-emergence effect at 20g / ha against DSIA in % Example Dosage AS number [g / ha] G ID 1-21 20 100 2-21 20 100 2-25 20 100 1-25 20 100 1-61 20 100 1-65 20 100 2-65 20 100 1-62 20 100 1-22 20 100 2-22 20 90 2-62 20 100 Table C-13: Pre-emergence effect at 80g / ha against DSIA in % Example Dosage AS number [g / ha] G I D 1-21 80 100 2-21 80 100 2-25 80 100 1-25 80 100 1-61 80 100 1-65 80 100 2-65 80 100 BCS231018 Abroad - 64 - 1-62 80 100 1-22 80 100 2-22 80 100 2-62 80 100 Table C-14: Pre-emergence effect at 20g / ha against H ECCG in % G Example Dosage C number [g / ha] HCE 1-21 20 100 2-21 20 90 2-25 20 90 1-25 20 90 1-61 20 100 1-65 20 100 2-65 20 90 1-62 20 90 2-22 20 90 2-62 20 90 Table C-15: Pre-emergence effect at 80g / ha against H ECCG in % G Example Dosage C number [g / ha] HCE 1-21 80 100 2-21 80 100 2-25 80 100 1-25 80 100 1-61 80 100 1-65 80 100 2-65 80 100 1-62 80 100 1-22 80 100 2-22 80 100 2-62 80 100 Table C-16: Pre-emergence effect at 20g / ha against L LROI in % Example dosage I R number [g / ha] L OL 1-65 20 80 1-2 20 90 BCS231018 Abroad - 65 - 2-2 20 80 2-5 20 80 Table C-17: Pre-emergence effect at 80g / ha against L LROI in % Example dosage I R number [g / ha] L O L 1-21 80 90 2-21 80 90 2-25 80 90 1-25 80 100 1-61 80 90 1-65 80 100 2-65 80 100 1-62 80 100 1-22 80 100 2-22 80 80 2-62 80 100 2-61 80 80 1-1 80 90 2-1 80 80 1-2 80 100 2-2 80 90 1-42 80 90 1-64 80 100 1-24 80 100 1-45 80 100 2-45 80 100 1-5 80 100 2-41 80 90 2-5 80 100 1-103 80 90 Table C-18: Pre-emergence effect at 20g / ha against T MINA in % Example dosage N I number [g / ha] TAM 1-21 20 90 2-25 20 90 1-25 20 90 1-61 20 100 1-65 20 100 2-65 20 100 BCS231018 Abroad - 66 - 1-62 20 100 2-61 20 90 1-1 20 80 2-1 20 80 1-2 20 100 2-2 20 100 1-42 20 100 1-41 20 90 1-64 20 90 1-24 20 90 1-45 20 100 2-45 20 90 1-5 20 100 2-41 20 90 2-5 20 90 1-103 20 90 Table C-19: Pre-emergence effect at 80g / ha against T MINA in % Example dosage NI number [g / ha] TAM 1-21 80 100 2-21 80 100 2-25 80 100 1-25 80 100 1-61 80 100 1-65 80 100 2-65 80 100 1-62 80 100 1-22 80 100 2-22 80 100 2-62 80 100 2-61 80 100 1-1 80 100 2-1 80 100 1-2 80 100 2-2 80 100 1-42 80 100 2-42 80 90 1-41 80 100 1-64 80 100 1-24 80 100 1-45 80 100 2-45 80 100 1-5 80 100 BCS231018 Abroad - 67 - 2-41 80 100 2-5 80 100 2-103 80 90 1-103 80 100Table C-20: Pre-emergence effect at 80g / ha against B PH U in %Example dosage U P number [g / ha] BHP 1-25 80 90 1-61 80 80 2-65 80 80 1-62 80 90 1-22 80 100 2-22 80 80Table C-21: Pre-emergence effect at 20g / ha against L PCO in %Example Dosage OC number [g / ha] L OP 1-65 20 90 2-65 20 90 Table C-22: Pre-emergence effect at 80g / ha against L PCO in % Example Dosage OC number [g / ha] LOP 1-21 80 90 2-21 80 80 1-25 80 90 1-61 80 90 1-65 80 90 2-65 80 90 Table C-23: Pre-emergence effect at 20g / ha against T SVEI in % I Example Dosage V number [g / ha] TES 1-21 20 90 2-21 20 90 BCS231018 Abroad - 68 - 2-25 20 90 1-25 20 90 1-61 20 100 1-65 20 100 2-65 20 100 1-62 20 100 1-22 20 80 Table C-24: Pre-emergence effect at 80g / ha against T SVEI in % I Example Dosage V number [g / ha] TES 1-21 80 100 2-21 80 100 2-25 80 100 1-25 80 100 1-61 80 100 1-65 80 100 2-65 80 100 1-62 80 100 1-22 80 100 2-22 80 100 2-62 80 100 Table C-25: Pre-emergence effect at 20g / ha against R VPEE in % Example dosage E P number [g / ha] REV 1-25 20 80 1-61 20 90 1-65 20 100 2-65 20 80 1-62 20 90 Table C-26: Pre-emergence effect at 80g / ha against R VPEE in % Example dosage E P number [g / ha] REV 1-21 80 100 2-21 80 80 2-25 80 90 1-25 80 90 BCS231018 Abroad - 69- 1-61 80 100 1-65 80 100 2-65 80 100 1-62 80 100 1-22 80 90 2-22 80 90 2-62 80 90 Table C-27: Pre-emergence effect at 20g / ha against O VTIR in % Example Dosage RT number [g / ha] O I V 1-21 20 100 2-21 20 100 2-25 20 100 1-25 20 100 1-61 20 100 1-65 20 100 2-65 20 100 1-62 20 100 1-22 20 100 2-22 20 90 2-62 20 80 2-61 20 80 1-1 20 90 1-2 20 100 2-2 20 90 1-42 20 90 1-41 20 100 1-45 20 100 2-45 20 100 1-5 20 100 2-41 20 100 2-5 20 100 Table C-28: Pre-emergence effect at 80g / ha against O VTIR in % Example Dosage RT number [g / ha] O I V 1-21 80 100 2-21 80 100 2-25 80 100 1-25 80 100 BCS231018 Abroad - 70- 1-61 80 100 1-65 80 100 2-65 80 100 1-62 80 100 1-22 80 100 2-22 80 90 2-62 80 100 2-61 80 100 1-1 80 100 2-1 80 100 1-2 80 100 2-2 80 100 1-42 80 100 1-41 80 100 1-64 80 100 1-24 80 100 1-45 80 100 2-45 80 100 1-5 80 100 2-41 80 100 2-5 80 100 Table C-29: Pre-emergence effect at 20g / ha against H KSCC in % Example Dosage CS number [g / ha] HCK 1-21 20 100 2-21 20 100 2-25 20 100 1-25 20 90 1-61 20 100 1-65 20 100 2-65 20 100 1-62 20 100 1-22 20 100 2-22 20 90 2-62 20 100 Table C-30: Pre-emergence effect at 80g / ha against H KSCC in % Example Dosage CS number [g / ha] HCK 1-21 80 100 BCS231018 Abroad - 71- 2-21 80 100 2-25 80 100 1-25 80 100 1-61 80 100 1-65 80 100 2-65 80 100 1-62 80 100 1-22 80 100 2-22 80 100 2-62 80 100 2. Herbicidal action against weeds in the nighttime. Seeds of mono- or dicotyledonous weeds or cultivars are placed in wood fiber pots in sandy loam soil, covered with soil and grown in the garden under good growing conditions. 2 to 3 weeks after sowing, other weed plants are treated in the single-leaf stage. The compounds according to the invention, formulated in the form of wettable powders (WP) or aqueous emulsion concentrates (EC), are then sprayed onto the green parts of the plant as a white suspension or emulsion at a water application rate of the equivalent of 600 to 80 µl / m² with the addition of 0.2% wetting agent. After approx.After 3 weeks of standing test plants in the greenhouse under optimal growth conditions, the effect of the three-part plants is visually assessed in comparison to untreated controls (herbicidal effect in %): 100% effect = plants have died, 0% effect = same as control plants). Compounds according to the invention demonstrated very good activity against a variety of important weeds. The following tables show examples of the post-emergence herbicidal effect of the compounds according to the invention, with the herbicidal effect given as a percentage. Table C-31: Post-emergence effect at 20g / ha gegeEnAM ZX in % Example number Dosage [g / ha] XMAEZ 2-21 20 0 Table C-32: Post-emergence effect at 20g / ha gegeRnZA TS in % S Example number Dosage [g / ha] AZ RT 2-21 20 0 BCS231018 Abroad -. 72- 1-22 20 20 2-22 20 10 2-62 20 20 1-1 20 20 2-1 20 0 1-2 20 0 2-2 20 10 2-42 20 0 1-64 20 0 1-24 20 20 1-5 20 20 2-41 20 10 2-103 20 0 1-103 20 0 Table C-33: Post-emergence effect at 80g / ha gegeRnZA TS in % S Example number Dosage [g / ha] AZ RT 2-2 80 20 2-42 80 0 2-103 80 0 1-103 80 10 Table C-34: Post-emergence effect at 20g / ha given ATH in % H Example number Dosage [g / ha] TUBA 1-21 20 100 2-21 20 100 2-25 20 100 1-61 20 100 1-65 20 100 2-65 20 100 1-62 20 100 1-22 20 100 2-22 20 100 2-62 20 90 BCS231018 Abroad - 73 - Table C-35: Post-emergence effect at 80g / ha against ATH in % H Example number Dosage [g / ha] TUBA 1-21 80 100 2-21 80 100 2-25 80 100 1-61 80 100 1-65 80 100 2-65 80 100 1-62 80 100 1-22 80 100 2-22 80 100 2-62 80 100 Table C-36: Post-emergence effect at 20g / ha against AMY in % Y Example number Dosage [g / ha] MO LA 1-2 20 90 2-2 20 80 1-42 20 80 1-5 20 90 Table C-37: Post-emergence effect at 80g / ha gegeLnO AMY in % Y Example number Dosage [g / ha] MO L A 1-21 80 80 2-25 80 100 1-25 80 90 1-61 80 100 1-65 80 90 2-65 80 100 1-62 80 100 1-22 80 100 2-22 80 80 2-62 80 90 2-61 80 90 1-1 80 80 2-1 80 80 1-2 80 100 BCS231018 Abroad - 74 - 2-2 80 80 1-42 80 90 2-42 80 80 1-45 80 95 2-45 80 95 1-5 80 100 2-5 80 95 Table C-38: Post-emergence effect at 20g / ha against MnA ARE in % E Example number Dosage [g / ha] RAMA 1-21 20 100 2-21 20 100 2-25 20 100 1-25 20 90 1-61 20 100 1-65 20 100 2-65 20 100 1-62 20 100 1-22 20 100 2-22 20 100 2-62 20 100 Table C-39: Post-emergence effect at 80g / ha against MnA ARE in % E Example number Dosage [g / ha] RAMA 1-21 80 100 2-21 80 100 2-25 80 100 1-25 80 90 1-61 80 100 1-65 80 100 2-65 80 100 1-62 80 100 1-22 80 100 2-22 80 100 2-62 80 100 BCS231018 Abroad - 75- Table C-40: Post-emergence effect at 20g / ha gegeIGnS DA in % A Example number Dosage [g / ha] SG I D 1-21 20 100 2-21 20 90 2-25 20 100 1-25 20 90 1-61 20 100 1-65 20 100 2-65 20 100 1-62 20 100 1-22 20 90 2-22 20 90 2-62 20 90 Table C-41: Post-emergence effect at 80g / ha gegeIGnS DA in % A Example number Dosage [g / ha] SG I D 1-21 80 100 2-21 80 100 2-25 80 100 1-25 80 90 1-61 80 100 1-65 80 100 2-65 80 100 1-62 80 100 1-22 80 100 2-22 80 90 2-62 80 90 Table C-42: Post-emergence effect at 20g / ha against OnLR LI in % I Example number Dosage [g / ha] R L O L 1-21 20 90 1-25 20 90 BCS231018 Abroad - 76 - Table C-43: Post-emergence effect at 80g / ha against OnLR LI in % I Example number Dosage [g / ha] R L O L1-21 80 100 2-25 80 100 1-25 80 90 1-61 80 90 1-65 80 100 2-65 80 100 1-62 80 100 1-22 80 100 2-22 80 100 2-62 80 90 2-61 80 90 1-1 80 80 2-1 80 80 1-2 80 90 2-2 80 80 1-24 80 95 1-5 80 95 2-5 80 95 Table C-44: Post-emergence effect at 20g / ha gegeAnT MIN in % Example number Dosage [g / ha] N I TAM 2-25 20 80 1-25 20 80 1-61 20 90 1-65 20 80 2-65 20 90 1-62 20 90 2-62 20 80 2-61 20 90 1-2 20 100 2-2 20 100 1-42 20 90 2-42 20 100 1-64 20 90 1-24 20 80 1-45 20 95 2-45 20 80 1-5 20 90 BCS231018 Abroad - 77 - 2-41 20 90 2-5 20 95 2-103 20 90 1-103 20 80 Table C-45: Post-emergence effect at 80g / ha gegeAnT MIN in % Example number Dosage [g / ha] N ITAM 2-21 80 80 2-25 80 100 1-25 80 90 1-61 80 100 1-65 80 100 2-65 80 100 1-62 80 100 1-22 80 80 2-22 80 80 2-62 80 90 2-61 80 90 1-1 80 80 2-1 80 90 1-2 80 100 2-2 80 100 1-42 80 100 2-42 80 100 1-41 80 95 1-64 80 100 1-24 80 95 1-45 80 95 2-45 80 95 1-5 80 100 2-41 80 95 2-5 80 95 2-103 80 90 1-103 80 90Table C-46: Post-emergence effect at 20g / ha gegHenB PU in % U Example number Dosage [g / ha] PBHP 1-21 20 90 2-21 20 80 BCS231018 Abroad - 78 - 2-25 20 90 1-25 20 90 1-61 20 80 1-65 20 90 2-65 20 80 1-62 20 80 1-22 20 80 2-22 20 80 2-62 20 80Table C-47: Post-emergence effect at 80g / ha of HenB PU in % U Example number Dosage [g / ha] PBHP 1-21 80 100 2-21 80 100 2-25 80 100 1-25 80 90 1-61 80 100 1-65 80 100 2-65 80 90 1-62 80 80 1-22 80 100 2-22 80 100 2-62 80 100 Table C-48: Post-emergence effect at 80g / ha applied OenLC PO in % O Example number Dosage [g / ha] C LOP 1-21 80 100 1-25 80 90 1-61 80 100 2-65 80 80 2-62 80 90 Table C-49: Post-emergence effect at 20g / ha against EenTV SI in % I Example number Dosage [g / ha] VT ES 1-21 20 100 2-25 20 100 BCS231018 Abroad - 79 - 1-25 20 90 1-61 20 100 1-65 20 100 2-65 20 100 1-62 20 100 1-22 20 100 2-22 20 100 2-62 20 100 Table C-50: Post-emergence effect at 80g / ha against EenTV SI in % I Example number Dosage [g / ha] VT ES 1-21 80 100 2-21 80 100 2-25 80 100 1-25 80 90 1-61 80 100 1-65 80 100 2-65 80 100 1-62 80 100 1-22 80 100 2-22 80 100 2-62 80 100 Table C-51: Post-emergence effect at 20g / ha against EnR VPE in % E Example number Dosage [g / ha] PREV 1-25 20 90 1-61 20 90 1-65 20 80 2-65 20 80 1-62 20 90 2-62 20 90 Table C-52: Post-emergence effect at 80g / ha against EnR VPE in % E Example number Dosage [g / ha] PREV 1-21 80 100 2-21 80 80 BCS231018 Abroad - 80- 2-25 80 80 1-25 80 90 1-61 80 100 1-65 80 100 2-65 80 90 1-62 80 100 1-22 80 100 2-22 80 90 2-62 80 90 Table C-53: Post-emergence effect at 20g / ha gegeIOnT VR in % R Example number Dosage [g / ha] TO I V 1-21 20 100 2-21 20 100 2-25 20 100 1-25 20 90 1-61 20 100 1-65 20 100 2-65 20 100 1-62 20 100 1-22 20 100 2-22 20 100 2-62 20 100 2-61 20 90 1-1 20 100 2-1 20 100 1-2 20 100 2-2 20 100 1-42 20 100 1-41 20 100 1-64 20 95 1-24 20 90 1-45 20 100 2-45 20 100 1-5 20 100 2-41 20 100 2-5 20 95 2-103 20 80 BCS231018 Abroad - 81 - Table C-54: Post-emergence effect at 80g / ha gegeIOnT VR in % R Example number Dosage [g / ha] TO IV 1-21 80 100 2-21 80 100 2-25 80 100 1-25 80 90 1-61 80 100 1-65 80 100 2-65 80 100 1-62 80 100 1-22 80 100 2-22 80 100 2-62 80 100 2-61 80 100 1-1 80 100 2-1 80 100 1-2 80 100 2-2 80 100 1-42 80 100 2-42 80 90 1-41 80 100 1-64 80 100 1-24 80 100 1-45 80 100 2-45 80 100 1-5 80 100 2-41 80 100 2-5 80 95 2-103 80 100 1-103 80 80 Table C-55: Post-emergence effect at 20g / ha against CnH KSC in % C Example number Dosage [g / ha] SHCK 1-21 20 100 2-21 20 90 2-25 20 100 1-25 20 90 1-61 20 100 1-65 20 100 2-65 20 100 BCS231018 Abroad - 82- 1-62 20 100 1-22 20 100 2-22 20 100 2-62 20 100 Table C-56: Post-emergence effect at 80g / ha against CnH KSC in % C Example number Dosage [g / ha] SHCK 1-21 80 100 2-21 80 100 2-25 80 100 1-25 80 90 1-61 80 100 1-65 80 100 2-65 80 100 1-62 80 100 1-22 80 100 2-22 80 100 2-62 80 100 3. Comparative trials In the following trials, the herbicidal effectiveness of numerous The compounds of the invention and the structurally closest ones known from WO2012 / 28579 and WO2012 / 2051540 are available under the above-mentioned conditions in pre-emergence and post-emergence. The example numbers listed in the tables.refer to the inventive compounds of the present application; the respective comparison compounds are disclosed in the above-mentioned documents but are not specifically named (compounds V-1 to V-6) and are referred to below by their IUPAC name: V-1: 3-Acetyl-2-chloro-4-methoxy-N-(1-methyl-1H-tetrazol-5-yl)benzamide V-2: 2-chloro-4-methoxy-N-(1-methyl-1H-tetrazol-5)-yl-propionylbenzamide V-3: 2-chloro-3-(cyclopropylcarbonyl)-4-methoxy-N-(m-1-ethyl-1H-tetrazol-5-yl)benzamide V-4: 3-Acetyl-2-chloro-N-(1-ethyl-1H-tetrazol-5-yl)-methoxybenzamide V-5: 2-Chloro-N-(1-ethyl-1H-tetrazol-5-yl)-4-metho-x3y-propionylbenzamide V-6: 2-Chloro-3-(cyclopropylcarbonyl)-N-(1-ethyl-1Htetrazol-5-yl)-4-methoxybenzamide Herbicidal action in pre-emergence: efg = according to the invention BCS231018 abroad -. 83- Example No. Dosage Herbicidal effect against (g ai / ha) ABUTH LOLRI SETVI VERPE 1-21, efg 80 100 90 100 100 V-1 80 70 50 80 80 Example No. Dosage Herbicidal effect against (g ai / ha) ABUTH LOLRI PHBPU 1-22, efg 80 100 100 100 V-2 80 80 70 70 Example No. Dosage Herbicidal effect against (g ai / ha) LOLRI PHBPU POLCO 1-25, efg 80 100 90 90 V-3 80 80 70 70 Example No. Dosage Herbicidal effect against (g ai / ha)ABUTH LOLRI SETVI VERPE1-61, efg 80 100 90 100 100 V-1 80 70 50 80 80 Example No. Dosage Herbicidal effect against (g ai / ha)ABUTH LOLRI PHBPU 1-62, efg 80 100 100 90 V-2 80 80 70 70 Example No. Dosage Herbicidal effect against (g ai / ha)LOLRI POLCO 1-65, efg 80 100 90 V-3 80 80 70 Example No. Dosage Herbicidal effect against (g ai / ha) ABUTH LOLRI PHBPU VERPE 2-21, efg 80 100 90 60 80 BCS231018 Abroad - 84- V-4 80 70 60 30 0 Example No. Dosage Herbicidal effect against (g ai / ha) ABUTH LOLRI PHBPU VIOTR 2-22, efg 80 100 80 80 90 V-5 80 70 60 60 70 Example No. Dosage Herbicidal effect against (g ai / ha) VIOTR 2-25, efg 80 100 V-6 80 80 Example No. Dosage Herbicidal effect against (g ai / ha) ABUTH AVEFA LOLRI VIOTR 2-62, efg 80 100 100 100 100 V-5 80 70 80 60 70 Example No. Dosage Herbicidal effect against (g ai / ha) POLCO VIOTR 2-65, efg 80 90 100 V-6 80 60 80 Example No. Dosage Herbicidal effect against (g ai / ha) ABUTH LOLRI PHBPU POLCO SETVI VIOTR 1-21, efg 20 100 70 60 50 90 100 V-1 20 70 30 0 30 40 80 Example No. Dosage Herbicidal effect against (g ai / ha) ABUTH ECHCG SETVI VIOTR 1-22, efg 20 100 70 80 100 V-2 20 50 50 50 0 BCS231018 Abroad - 85- Example No. Dosage Herbicidal effect against (g ai / ha) ABUTH AVEFA PHBPU POLCO SETVI VIOTR 1-25, efg 20 90 90 40 50 90 100 V-3 20 60 70 0 0 70 70 Example No. Dosage Herbicidal effect against (g ai / ha)ABUTH LOLRI MATIN PHBPU POLCO SETVI VERPE VIOTR1-61, efg 20 100 70 100 70 70 100 90 100 V-1 20 70 30 80 0 30 40 60 80 Example No. Dosage Herbicidal activity against (g ai / ha)ABUTH AVEFA ECHCG POLCO SETVI VERPE VIOTR1-62, efg 20 100 100 90 60 100 90 100 V-2 20 50 70 50 0 50 0 0 Example No. Dosage Herbicidal activity against (g ai / ha)ABUTH ALOMY ECHCG PHBPU POLCO SETVI VERPE VIOTR1-65, efg 20 100 100 100 60 90 100 100 100 V-3 20 60 80 80 0 0 70 80 70 Example No. Dosage Herbicidal effect against (g ai / ha) ABUTH ECHCG LOLRI PHBPU SETVI VERPE 2-21, efg 20 100 90 70 60 90 50 V-4 20 0 60 10 0 0 0 Example No. Dosage Herbicidal effect against (g ai / ha) ABUTH ECHCG LOLRI PHBPU SETVI VIOTR 2-22, efg 20 100 90 50 60 70 90 V-5 20 0 40 0 ​​0 30 30 BCS231018 Abroad - 86- Example No. Dosage Herbicidal effect against (g ai / ha) ABUTH VIOTR 2-25, efg 20 90 100 V-6 20 50 30 Example No. Dosage Herbicidal effect against (g ai / ha) ABUTH ECHCG LOLRI PHBPU SETVI VIOTR 2-62, efg 20 100 90 70 40 70 80 V-5 20 0 40 0 ​​0 30 30 Example No. Dosage Herbicidal action against (g ai / ha) ABUTH POLCO SETVI VERPE VIOTR 2-65, efg 20 100 90 100 80 100 V-6 20 50 0 80 60 30 Post-emergence herbicidal action: efg = according to the invention, compound of the present invention. Application Example No. Dosage Herbicidal action against (g ai / ha) ABUTH ALOMY AVEFA ECHCG LOLRI SETVI VERPE VIOTR1-21, efg 20 100 50 90 100 90 100 70 100 V-1 20 70 0 60 70 30 60 30 80 Example No. Dosage Herbicidal effect against (g ai / ha) ABUTH AVEFA LOLRI SETVI 1-22, efg 20 100 100 70 100 V-2 20 70 60 30 80 Example No. Dosage Herbicidal effect against (g ai / ha) AVEFA LOLRI VERPE 1-25, efg 20 90 90 90 V-3 20 70 50 70 BCS231018 Abroad - 87- Example No. Dosage Herbicidal effect against (g ai / ha)ABUTH ALOMY AVEFA ECHCG LOLRI MATIN SETVI VERPE VIOTR1-61, efg 20 100 60 100 100 60 90 100 90 100 V-1 20 70 0 60 70 30 70 60 30 80 Example No. Dosage Herbicidal effect against (g ai / ha) ABUTH AVEFA LOLRI SETVI VERPE 1-62, efg 20 100 90 50 100 90 V-2 20 70 60 30 80 60 Example No. Dosage Herbicidal effect against (g ai / ha) ABUTH AVEFA SETVI VIOTR 1-65, efg 20 100 100 100 100 V-3 20 60 70 80 80 Example No. Dosage Herbicidal effect against (g ai / ha) ABUTH AVEFA ECGCG LOLRI VERPE VIOTR 2-21, efg 20 100 40 100 60 60 100 V-4 20 70 0 70 0 0 70 Example No. Dosage Herbicidal effect against (g ai / ha) ABUTH LOLRI SETVI VERPE VIOTR 2-22, efg 20 100 30 100 70 100 V-5 20 70 0 40 0 ​​70 Example No. Dosage Herbicidal effect against (g ai / ha) ABUTH AVEFA LOLRI SETVI VIOTR 2-25, efg 20 100 90 60 100 100 V-6 20 40 70 20 50 50 BCS231018 Abroad - 88- Example No. Dosage Herbicidal effect against (g ai / ha) ABUTH AVEFA LOLRI SETVI VERPE VIOTR 2-62, efg 20 90 80 60 100 90 100 V-5 20 70 60 0 40 0 ​​70 Example No. Dosage Herbicidal effect against (g ai / ha) ABUTH LOLRI SETVI VERPE VIOTR 2-65, efg 20 100 50 100 80 100 V-6 20 40 20 50 60 50

Claims

BCS231018 Abroad - 89 - Claims:

1. 3-Acylbenzamides of formula (I) or their salts where the symbols and indices have the following meaning: R x means (C1-C6)-alkyl, X means halogen, (C1-C6)-alkyl or (C3-C6)-cycloalkyl, Y means halogen-( 1 CC 6 )-alkoxy, Z means (C 1 -C 6 )-alkyl, (C 3 -C 6 )-cycloalkyl, (C 2 -C 6 )-alkenyl, (C 2 -C 6 )-alkynyl, halogen-(C 1 - C 6 )-alkyl, (C 1 -C 6 )-alkyl-O-(C 1 -C 6 )-alkyl or (C 3 -C 6 )-Cycloalkyl-(C 1 -C 6 )-alkyl, where (C 3 -C 6 )-cycloalkyl by m residues 1 R is substituted, R 1 means halogen, ( 1 CC 6 )-alkyl, halogen-(C 1 -C 6 )-alkyl or (C 1 -C 6)-alkyl-O, and m is 0, 1, 2 or 3.

2. 3-Acyl-benzamides according to claim 1, wherein the alkyls have the following meanings: R x means (C 1 -C 6 )-alkyl, X is halogen, ( 1 CC 6 )-alkyl or (C 3 -C 6 )-cycloalkyl, Y is OC 3 F, OCHF 2 , OCH 2 CHF 2 or OCF 2 Me, Z means (C 1 -C 6 )-alkyl, (C 3 -C 6 )-cycloalkyl, (C 2 -C 6 )-alkenyl, (C 2 -C 6 )-alkynyl, halogen-(C 1 - C 6 )-alkyl, (C 1 -C 6 )-alkyl-O-(C 1 -C 6 )-alkyl or (C 3 -C 6 )-Cycloalkyl-(C 1 -C 6 )-alkyl, where (C 3 -C 6 )-cycloalkyl by m residues 1 R is substituted, R 1 means halogen, ( 1 CC 6 )-alkyl or halogen-(C 1 -C 6)-alkyl, and m is 0, 1 or 2.

3. 3-Acyl-benzamides according to claim 1 or, where S dymbole have the following meanings: R x means Me, Et BCS231018 Abroad - 90- X is chlorine, bromine, methyl, ethyl or cyclopyrene, Y is OC3F, OCHF2 or OCH2CHF2, and Z is methyl, ethyl, n-propyl, isopropyl, chloropropyl, butyl, isobutyl, sec-butyl, vinyl, allyl, ethynyl, prop-1-yn-1-yl, methoxymethyl, chloromethyl, cyclopropylmethyl, 1-methylcyclopropyl or difluoromethyl.

4. Herbicidal compositions comprising at least one 3-Iα-becynzamide according to any one of claims 1 to 3 in a mixture with formulation auxiliaries.

5. Herbicidal compositions according to claim 4 comprising, in combination, another pesticidally active substance from the group consisting of insecticides, acaricides, herbicides, safeners and growth regulators.

6. A method for controlling unwanted plants, which comprises applying an effective amount of at least one 3-acyl-benzamide according to any one of claims 1 to 3 or of herbicidal compositions according to claim 4 or 5 to the plant or to the site of unwanted plant growth. 7.Use of 3-acyl-benzamides of the formula (I) according to any one of claims 1 to 3 or of herbicidal compositions according to claim 4 or 5 for controlling undesirable plants.

8. Use according to claim 7, characterized in that the 3-acyl-benzamides of the formula (I) are, for example, ur Bekämpfung unerwünschter Pflanzen in Kulturoen N vutzpflanzen eingesetzt werden.

9. Use according to claim 8, characterized in that the crop plants are transgenic crop plants.

10. Compounds of formula (II), where the symbols and indices have the following meaning: L means halogen or 2 OR, X means halogen, ( 1 CC 6 )-alkyl or (C 3 -C 6 )-cycloalkyl, Y is halogen-( 1 CC 6 )-alkoxy, BCS231018 Abroad - 91 - Z means (C1-C6)-alkyl, (C3-C6)-cycloalkyl, (C2-C6)-alkenyl, (C2-C6)-alkynyl, halogen-(C1-C6)-alkyl, (C1-C6)-alkyl-O-(C1-C6)-alkyl or (C3-C6)-cycloalkyl-(C1-C6)-alkyl, where (C3-C6)-cycloalkyl is replaced by m radicals 1R is substituted, R 1 means halogen, (1C-C6)-alkyl, halogen-(C1-C6)-alkyl or (C1-C6)-alkyl-O, and R 2 bedeutet Wasserstoff oder1- (C 6)-Alkyl.

11. Compounds of formula (II) according to claim 1, in which L is chlorine, methoxy or hydroxy, X is chlorine, bromine, methyl, ethyl or cyclopyrene, Y is OC3F, OCHF2 or OCH2CHF2 and Z is methyl, ethyl, n-propyl, iso-propyl, cyclopropyl, butyl, iso-butyl, sec-butyl, vinyl, allyl, ethynyl, prop-1-yn-1-yl, methoxymethyl, chloromethyl, cyclopropylmethyl, 1-methylcyclopropyl or difluoromethyl.